ID   1433B_HUMAN             Reviewed;         246 AA.
AC   P31946; A8K9K2; E1P616;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   09-JAN-2013, entry version 149.
DE   RecName: Full=14-3-3 protein beta/alpha;
DE   AltName: Full=Protein 1054;
DE   AltName: Full=Protein kinase C inhibitor protein 1;
DE            Short=KCIP-1;
DE   Contains:
DE     RecName: Full=14-3-3 protein beta/alpha, N-terminally processed;
GN   Name=YWHAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Keratinocyte;
RX   MEDLINE=93294871; PubMed=8515476; DOI=10.1006/jmbi.1993.1346;
RA   Leffers H., Madsen P., Rasmussen H.H., Honore B., Andersen A.H.,
RA   Walbum E., Vandekerckhove J., Celis J.E.;
RT   "Molecular cloning and expression of the transformation sensitive
RT   epithelial marker stratifin. A member of a protein family that has
RT   been involved in the protein kinase C signalling pathway.";
RL   J. Mol. Biol. 231:982-998(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=21638749; PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 1-11; 14-57; 63-70; 106-117; 130-169 AND 215-246,
RP   CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT MET-1 AND THR-2, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Colon carcinoma;
RA   Bienvenut W.V., Zebisch A., Kolch W.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [7]
RP   PROTEIN SEQUENCE OF 3-20.
RC   TISSUE=Platelet;
RX   MEDLINE=22608298; PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [8]
RP   INTERACTION WITH AANAT.
RX   PubMed=11427721; DOI=10.1073/pnas.141118798;
RA   Ganguly S., Gastel J.A., Weller J.L., Schwartz C., Jaffe H.,
RA   Namboodiri M.A., Coon S.L., Hickman A.B., Rollag M., Obsil T.,
RA   Beauverger P., Ferry G., Boutin J.A., Klein D.C.;
RT   "Role of a pineal cAMP-operated arylalkylamine N-acetyltransferase/14-
RT   3-3-binding switch in melatonin synthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:8083-8088(2001).
RN   [9]
RP   INTERACTION WITH CRTC2.
RX   PubMed=15454081; DOI=10.1016/j.cell.2004.09.015;
RA   Screaton R.A., Conkright M.D., Katoh Y., Best J.L., Canettieri G.,
RA   Jeffries S., Guzman E., Niessen S., Yates J.R. III, Takemori H.,
RA   Okamoto M., Montminy M.;
RT   "The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive
RT   coincidence detector.";
RL   Cell 119:61-74(2004).
RN   [10]
RP   INTERACTION WITH SSH1.
RX   PubMed=15159416; DOI=10.1083/jcb.200401136;
RA   Nagata-Ohashi K., Ohta Y., Goto K., Chiba S., Mori R., Nishita M.,
RA   Ohashi K., Kousaka K., Iwamatsu A., Niwa R., Uemura T., Mizuno K.;
RT   "A pathway of neuregulin-induced activation of cofilin-phosphatase
RT   Slingshot and cofilin in lamellipodia.";
RL   J. Cell Biol. 165:465-471(2004).
RN   [11]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS], AND MASS SPECTROMETRY.
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [12]
RP   INTERACTION WITH YAP1.
RX   PubMed=17974916; DOI=10.1101/gad.1602907;
RA   Zhao B., Wei X., Li W., Udan R.S., Yang Q., Kim J., Xie J.,
RA   Ikenoue T., Yu J., Li L., Zheng P., Ye K., Chinnaiyan A., Halder G.,
RA   Lai Z.C., Guan K.L.;
RT   "Inactivation of YAP oncoprotein by the Hippo pathway is involved in
RT   cell contact inhibition and tissue growth control.";
RL   Genes Dev. 21:2747-2761(2007).
RN   [13]
RP   INTERACTION WITH ROR2, FUNCTION, PHOSPHORYLATION, DIMERIZATION, AND
RP   MASS SPECTROMETRY.
RX   PubMed=17717073; DOI=10.1210/me.2007-0323;
RA   Liu Y., Ross J.F., Bodine P.V.N., Billiard J.;
RT   "Homodimerization of Ror2 tyrosine kinase receptor induces 14-3-
RT   3(beta) phosphorylation and promotes osteoblast differentiation and
RT   bone formation.";
RL   Mol. Endocrinol. 21:3050-3061(2007).
RN   [14]
RP   INTERACTION WITH GAB2.
RX   PubMed=19172738; DOI=10.1038/emboj.2008.159;
RA   Brummer T., Larance M., Herrera Abreu M.T., Lyons R.J., Timpson P.,
RA   Emmerich C.H., Fleuren E.D.G., Lehrbach G.M., Schramek D.,
RA   Guilhaus M., James D.E., Daly R.J.;
RT   "Phosphorylation-dependent binding of 14-3-3 terminates signalling by
RT   the Gab2 docking protein.";
RL   EMBO J. 27:2305-2316(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [16]
RP   FUNCTION, AND INTERACTION WITH SRPK2.
RX   PubMed=19592491; DOI=10.1074/jbc.M109.026237;
RA   Jang S.W., Liu X., Fu H., Rees H., Yepes M., Levey A., Ye K.;
RT   "Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell
RT   cycle and cell death in neurons.";
RL   J. Biol. Chem. 284:24512-24525(2009).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-70 AND LYS-117, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 1-239, MASS SPECTROMETRY,
RP   INTERACTION WITH PHOSPHOSERINE MOTIFS, AND SUBUNIT.
RX   PubMed=17085597; DOI=10.1073/pnas.0605779103;
RA   Yang X., Lee W.H., Sobott F., Papagrigoriou E., Robinson C.V.,
RA   Grossmann J.G., Sundstroem M., Doyle D.A., Elkins J.M.;
RT   "Structural basis for protein-protein interactions in the 14-3-3
RT   protein family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:17237-17242(2006).
RN   [20]
RP   VARIANT ILE-99.
RX   PubMed=21248752; DOI=10.1038/nature09639;
RA   Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P.,
RA   Davies H., Jones D., Lin M.L., Teague J., Bignell G., Butler A.,
RA   Cho J., Dalgliesh G.L., Galappaththige D., Greenman C., Hardy C.,
RA   Jia M., Latimer C., Lau K.W., Marshall J., McLaren S., Menzies A.,
RA   Mudie L., Stebbings L., Largaespada D.A., Wessels L.F.A., Richard S.,
RA   Kahnoski R.J., Anema J., Tuveson D.A., Perez-Mancera P.A.,
RA   Mustonen V., Fischer A., Adams D.J., Rust A., Chan-On W., Subimerb C.,
RA   Dykema K., Furge K., Campbell P.J., Teh B.T., Stratton M.R.,
RA   Futreal P.A.;
RT   "Exome sequencing identifies frequent mutation of the SWI/SNF complex
RT   gene PBRM1 in renal carcinoma.";
RL   Nature 469:539-542(2011).
CC   -!- FUNCTION: Adapter protein implicated in the regulation of a large
CC       spectrum of both general and specialized signaling pathways. Binds
CC       to a large number of partners, usually by recognition of a
CC       phosphoserine or phosphothreonine motif. Binding generally results
CC       in the modulation of the activity of the binding partner. Negative
CC       regulator of osteogenesis. Blocks the nuclear translocation of the
CC       phosphorylated form (by AKT1) of SRPK2 and antagonizes its
CC       stimulatory effect on cyclin D1 expression resulting in blockage
CC       of neuronal apoptosis elicited by SRPK2.
CC   -!- SUBUNIT: Homodimer. Interacts with SAMSN1 and KRPCE (By
CC       similarity). Interacts with SSH1 and TORC2/CRTC2. Interacts with
CC       ABL1; the interaction results in cytoplasmic location of ABL1 and
CC       inhibition of cABL-mediated apoptosis. Interacts with ROR2
CC       (dimer); the interaction results in phosphorylation of YWHAB on
CC       tyrosine residues. Interacts with GAB2 and YAP1 (phosphorylated
CC       form). Interacts with the phosphorylated (by AKT1) form of SRPK2.
CC       Interacts with PKA-phosphorylated AANAT.
CC   -!- INTERACTION:
CC       Q76353:- (xeno); NbExp=3; IntAct=EBI-359815, EBI-6248077;
CC       Q9P0K1-3:ADAM22; NbExp=2; IntAct=EBI-359815, EBI-1567267;
CC       O00257:CBX4; NbExp=2; IntAct=EBI-359815, EBI-722425;
CC       P30304:CDC25A; NbExp=8; IntAct=EBI-359815, EBI-747671;
CC       O94921:CDK14; NbExp=5; IntAct=EBI-359815, EBI-1043945;
CC       Q9NYF0:DACT1; NbExp=4; IntAct=EBI-359815, EBI-3951744;
CC       Q13627-2:DYRK1A; NbExp=3; IntAct=EBI-359815, EBI-1053621;
CC       Q11184:let-756 (xeno); NbExp=2; IntAct=EBI-359815, EBI-3843983;
CC       Q5S007:LRRK2; NbExp=3; IntAct=EBI-359815, EBI-5323863;
CC       Q99683:MAP3K5; NbExp=3; IntAct=EBI-359815, EBI-476263;
CC       Q7KZI7:MARK2; NbExp=2; IntAct=EBI-359815, EBI-516560;
CC       P27448:MARK3; NbExp=2; IntAct=EBI-359815, EBI-707595;
CC       P04049:RAF1; NbExp=10; IntAct=EBI-359815, EBI-365996;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Melanosome. Note=Identified by
CC       mass spectrometry in melanosome fractions from stage I to stage
CC       IV.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=Long;
CC         IsoId=P31946-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=P31946-2; Sequence=VSP_018632;
CC         Note=Acetylated on Met-1 (By similarity);
CC   -!- PTM: The alpha, brain-specific form differs from the beta form in
CC       being phosphorylated (By similarity).
CC   -!- PTM: Isoform Short contains a N-acetylmethionine at position 1 (By
CC       similarity).
CC   -!- SIMILARITY: Belongs to the 14-3-3 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X57346; CAA40621.1; -; mRNA.
DR   EMBL; AK292717; BAF85406.1; -; mRNA.
DR   EMBL; AL008725; CAA15497.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75893.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75894.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75896.1; -; Genomic_DNA.
DR   EMBL; BC001359; AAH01359.1; -; mRNA.
DR   IPI; IPI00216318; -.
DR   IPI; IPI00759832; -.
DR   PIR; S34755; S34755.
DR   RefSeq; NP_003395.1; NM_003404.3.
DR   RefSeq; NP_647539.1; NM_139323.2.
DR   UniGene; Hs.643544; -.
DR   PDB; 2BQ0; X-ray; 2.50 A; A/B=1-239.
DR   PDB; 2C23; X-ray; 2.65 A; A=1-239.
DR   PDB; 4DNK; X-ray; 2.20 A; A/B=1-246.
DR   PDBsum; 2BQ0; -.
DR   PDBsum; 2C23; -.
DR   PDBsum; 4DNK; -.
DR   ProteinModelPortal; P31946; -.
DR   SMR; P31946; 1-234.
DR   DIP; DIP-743N; -.
DR   IntAct; P31946; 53.
DR   MINT; MINT-99570; -.
DR   STRING; P31946; -.
DR   PhosphoSite; P31946; -.
DR   DMDM; 1345590; -.
DR   Cornea-2DPAGE; P31946; -.
DR   OGP; P31946; -.
DR   REPRODUCTION-2DPAGE; IPI00216318; -.
DR   PaxDb; P31946; -.
DR   PRIDE; P31946; -.
DR   DNASU; 7529; -.
DR   Ensembl; ENST00000353703; ENSP00000300161; ENSG00000166913.
DR   Ensembl; ENST00000372839; ENSP00000361930; ENSG00000166913.
DR   GeneID; 7529; -.
DR   KEGG; hsa:7529; -.
DR   UCSC; uc002xmt.3; human.
DR   CTD; 7529; -.
DR   GeneCards; GC20P043515; -.
DR   HGNC; HGNC:12849; YWHAB.
DR   HPA; CAB003759; -.
DR   HPA; HPA007925; -.
DR   HPA; HPA011212; -.
DR   MIM; 601289; gene.
DR   neXtProt; NX_P31946; -.
DR   PharmGKB; PA37438; -.
DR   eggNOG; COG5040; -.
DR   HOGENOM; HOG000240379; -.
DR   HOVERGEN; HBG050423; -.
DR   InParanoid; P31946; -.
DR   KO; K16197; -.
DR   OMA; CNDVLXT; -.
DR   OrthoDB; EOG4N30PR; -.
DR   PhylomeDB; P31946; -.
DR   Pathway_Interaction_DB; a6b1_a6b4_integrin_pathway; a6b1 and a6b4 Integrin signaling.
DR   Pathway_Interaction_DB; pi3kciaktpathway; Class I PI3K signaling events mediated by Akt.
DR   Pathway_Interaction_DB; foxopathway; FoxO family signaling.
DR   Pathway_Interaction_DB; insulin_glucose_pathway; Insulin-mediated glucose transport.
DR   Pathway_Interaction_DB; p38_mk2pathway; p38 signaling mediated by MAPKAP kinases.
DR   Pathway_Interaction_DB; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes.
DR   Pathway_Interaction_DB; hdac_classii_pathway; Signaling events mediated by HDAC Class II.
DR   Pathway_Interaction_DB; pi3kplctrkpathway; Trk receptor signaling mediated by PI3K and PLC-gamma.
DR   Reactome; REACT_111045; Developmental Biology.
DR   Reactome; REACT_111102; Signal Transduction.
DR   Reactome; REACT_11123; Membrane Trafficking.
DR   Reactome; REACT_116125; Disease.
DR   Reactome; REACT_21257; Metabolism of RNA.
DR   Reactome; REACT_578; Apoptosis.
DR   Reactome; REACT_6900; Immune System.
DR   Reactome; REACT_71; Gene Expression.
DR   EvolutionaryTrace; P31946; -.
DR   GenomeRNAi; 7529; -.
DR   NextBio; 29453; -.
DR   ArrayExpress; P31946; -.
DR   Bgee; P31946; -.
DR   CleanEx; HS_YWHAB; -.
DR   Genevestigator; P31946; -.
DR   GermOnline; ENSG00000166913; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0017053; C:transcriptional repressor complex; IEA:Compara.
DR   GO; GO:0003714; F:transcription corepressor activity; IEA:Compara.
DR   GO; GO:0000186; P:activation of MAPKK activity; TAS:Reactome.
DR   GO; GO:0006915; P:apoptotic process; TAS:Reactome.
DR   GO; GO:0007411; P:axon guidance; TAS:Reactome.
DR   GO; GO:0051220; P:cytoplasmic sequestering of protein; IDA:BHF-UCL.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0010467; P:gene expression; TAS:Reactome.
DR   GO; GO:0035329; P:hippo signaling cascade; TAS:Reactome.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0016071; P:mRNA metabolic process; TAS:Reactome.
DR   GO; GO:0035308; P:negative regulation of protein dephosphorylation; IDA:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-dependent; IEA:Compara.
DR   GO; GO:0048011; P:nerve growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0006605; P:protein targeting; IEA:Compara.
DR   GO; GO:0007265; P:Ras protein signal transduction; TAS:Reactome.
DR   Gene3D; 1.20.190.20; 14-3-3; 1.
DR   InterPro; IPR000308; 14-3-3.
DR   InterPro; IPR023409; 14-3-3_CS.
DR   InterPro; IPR023410; 14-3-3_domain.
DR   PANTHER; PTHR18860; PTHR18860; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   SMART; SM00101; 14_3_3; 1.
DR   SUPFAM; SSF48445; 14-3-3; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    246       14-3-3 protein beta/alpha.
FT                                /FTId=PRO_0000367900.
FT   INIT_MET      1      1       Removed; alternate.
FT   CHAIN         2    246       14-3-3 protein beta/alpha, N-terminally
FT                                processed.
FT                                /FTId=PRO_0000000003.
FT   SITE         58     58       Interaction with phosphoserine on
FT                                interacting protein (By similarity).
FT   SITE        129    129       Interaction with phosphoserine on
FT                                interacting protein (By similarity).
FT   MOD_RES       1      1       N-acetylmethionine; in 14-3-3 protein
FT                                beta/alpha; alternate.
FT   MOD_RES       2      2       N-acetylthreonine; in 14-3-3 protein
FT                                beta/alpha, N-terminally processed.
FT   MOD_RES       6      6       Phosphoserine.
FT   MOD_RES      70     70       N6-acetyllysine.
FT   MOD_RES     117    117       N6-acetyllysine.
FT   MOD_RES     186    186       Phosphoserine (By similarity).
FT   VAR_SEQ       1      2       Missing (in isoform Short).
FT                                /FTId=VSP_018632.
FT   VARIANT      99     99       V -> I (found in a renal cell carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_064762.
FT   HELIX         5     17
FT   HELIX        21     33
FT   HELIX        40     69
FT   HELIX        75    105
FT   HELIX       107    110
FT   HELIX       114    133
FT   HELIX       139    161
FT   HELIX       167    182
FT   HELIX       187    202
FT   HELIX       203    207
FT   TURN        210    212
FT   HELIX       213    232
SQ   SEQUENCE   246 AA;  28082 MW;  6BE1A9BF97468017 CRC64;
     MTMDKSELVQ KAKLAEQAER YDDMAAAMKA VTEQGHELSN EERNLLSVAY KNVVGARRSS
     WRVISSIEQK TERNEKKQQM GKEYREKIEA ELQDICNDVL ELLDKYLIPN ATQPESKVFY
     LKMKGDYFRY LSEVASGDNK QTTVSNSQQA YQEAFEISKK EMQPTHPIRL GLALNFSVFY
     YEILNSPEKA CSLAKTAFDE AIAELDTLNE ESYKDSTLIM QLLRDNLTLW TSENQGDEGD
     AGEGEN
//
ID   1433E_HUMAN             Reviewed;         255 AA.
AC   P62258; B3KY71; D3DTH5; P29360; P42655; Q4VJB6; Q53XZ5; Q63631;
AC   Q7M4R4;
DT   05-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   09-JAN-2013, entry version 107.
DE   RecName: Full=14-3-3 protein epsilon;
DE            Short=14-3-3E;
GN   Name=YWHAE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=95372385; PubMed=7644510; DOI=10.1073/pnas.92.17.7892;
RA   Conklin D.S., Galaktionov K., Beach D.;
RT   "14-3-3 proteins associate with cdc25 phosphatases.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:7892-7896(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   MEDLINE=97011338; PubMed=8858348;
RA   Chong S.S., Tanigami A., Roschke A.V., Ledbetter D.H.;
RT   "14-3-3 epsilon has no homology to LIS1 and lies telomeric to it on
RT   chromosome 17p13.3 outside the Miller-Dieker syndrome chromosome
RT   region.";
RL   Genome Res. 6:735-741(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=96300316; PubMed=8684458; DOI=10.1038/382308a0;
RA   Jin D.-Y., Lyu M.S., Kozak C.A., Jeang K.-T.;
RT   "Function of 14-3-3 proteins.";
RL   Nature 382:308-308(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SV), AND ALTERNATIVE SPLICING.
RC   TISSUE=Brain;
RX   PubMed=20417184; DOI=10.1016/j.bbrc.2010.04.104;
RA   Han D., Ye G., Liu T., Chen C., Yang X., Wan B., Pan Y., Yu L.;
RT   "Functional identification of a novel 14-3-3 epsilon splicing variant
RT   suggests dimerization is not necessary for 14-3-3 epsilon to inhibit
RT   UV-induced apoptosis.";
RL   Biochem. Biophys. Res. Commun. 396:401-406(2010).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RA   Luk S.C.W., Lee C.Y., Waye M.M.Y.;
RT   "Sequence determination of human epsilon 14-3-3 protein.";
RL   Submitted (JUN-1995) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Tanigami A., Chong S.S., Ledbetter D.H.;
RT   "14-3-3 epsilon genomic sequence.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND SV).
RC   TISSUE=Caudate nucleus, Heart, and Subthalamic nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   PROTEIN SEQUENCE OF 1-19.
RC   TISSUE=Platelet;
RX   MEDLINE=22608298; PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [12]
RP   PROTEIN SEQUENCE OF 1-19; 30-50 AND 131-170, ACETYLATION AT MET-1, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (MAY-2005) to UniProtKB.
RN   [13]
RP   PROTEIN SEQUENCE OF 103-108; 120-123; 131-141 AND 143-153.
RC   TISSUE=Histiocytic lymphoma;
RX   MEDLINE=91224664; PubMed=2026444;
RA   Demeter J., Medzihradszky D., Kha H., Goetzl E.J., Turck C.W.;
RT   "Isolation and partial characterization of the structures of
RT   fibroblast activating factor-related proteins from U937 cells.";
RL   Immunology 72:350-354(1991).
RN   [14]
RP   PROTEIN SEQUENCE OF 131-141 AND 154-190, AND MASS SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [15]
RP   INTERACTION WITH HCV CORE PROTEIN.
RX   MEDLINE=20111292; PubMed=10644344;
RX   DOI=10.1128/JVI.74.4.1736-1741.2000;
RA   Aoki H., Hayashi J., Moriyama M., Arakawa Y., Hino O.;
RT   "Hepatitis C virus core protein interacts with 14-3-3 protein and
RT   activates the kinase Raf-1.";
RL   J. Virol. 74:1736-1741(2000).
RN   [16]
RP   INTERACTION WITH AANAT.
RX   PubMed=11427721; DOI=10.1073/pnas.141118798;
RA   Ganguly S., Gastel J.A., Weller J.L., Schwartz C., Jaffe H.,
RA   Namboodiri M.A., Coon S.L., Hickman A.B., Rollag M., Obsil T.,
RA   Beauverger P., Ferry G., Boutin J.A., Klein D.C.;
RT   "Role of a pineal cAMP-operated arylalkylamine N-acetyltransferase/14-
RT   3-3-binding switch in melatonin synthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:8083-8088(2001).
RN   [17]
RP   INTERACTION WITH CDKN1B, AND SUBCELLULAR LOCATION.
RX   PubMed=12042314; DOI=10.1074/jbc.M203668200;
RA   Fujita N., Sato S., Katayama K., Tsuruo T.;
RT   "Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3
RT   and cytoplasmic localization.";
RL   J. Biol. Chem. 277:28706-28713(2002).
RN   [18]
RP   INTERACTION WITH GRB10.
RX   PubMed=15722337; DOI=10.1074/jbc.M501477200;
RA   Urschel S., Bassermann F., Bai R.Y., Munch S., Peschel C., Duyster J.;
RT   "Phosphorylation of grb10 regulates its interaction with 14-3-3.";
RL   J. Biol. Chem. 280:16987-16993(2005).
RN   [19]
RP   INTERACTION WITH ABL1, AND MASS SPECTROMETRY.
RX   PubMed=15696159; DOI=10.1038/ncb1228;
RA   Yoshida K., Yamaguchi T., Natsume T., Kufe D., Miki Y.;
RT   "JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of
RT   c-Abl in the apoptotic response to DNA damage.";
RL   Nat. Cell Biol. 7:278-285(2005).
RN   [20]
RP   INTERACTION WITH YWHAZ.
RX   PubMed=16376338; DOI=10.1016/j.febslet.2005.12.024;
RA   Gu Y.-M., Jin Y.-H., Choi J.-K., Baek K.-H., Yeo C.-Y., Lee K.-Y.;
RT   "Protein kinase A phosphorylates and regulates dimerization of 14-3-3
RT   epsilon.";
RL   FEBS Lett. 580:305-310(2006).
RN   [21]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS], AND MASS SPECTROMETRY.
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [22]
RP   INTERACTION WITH GAB2.
RX   PubMed=19172738; DOI=10.1038/emboj.2008.159;
RA   Brummer T., Larance M., Herrera Abreu M.T., Lyons R.J., Timpson P.,
RA   Emmerich C.H., Fleuren E.D.G., Lehrbach G.M., Schramek D.,
RA   Guilhaus M., James D.E., Daly R.J.;
RT   "Phosphorylation-dependent binding of 14-3-3 terminates signalling by
RT   the Gab2 docking protein.";
RL   EMBO J. 27:2305-2316(2008).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-210, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [24]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT THR-38 AND SER-210, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [25]
RP   INTERACTION WITH SRPK2.
RX   PubMed=19592491; DOI=10.1074/jbc.M109.026237;
RA   Jang S.W., Liu X., Fu H., Rees H., Yepes M., Levey A., Ye K.;
RT   "Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell
RT   cycle and cell death in neurons.";
RL   J. Biol. Chem. 284:24512-24525(2009).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-210, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [27]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-50; LYS-69; LYS-118 AND
RP   LYS-123, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 1-233, MASS SPECTROMETRY,
RP   INTERACTION WITH PHOSPHOSERINE MOTIFS, AND SUBUNIT.
RX   PubMed=17085597; DOI=10.1073/pnas.0605779103;
RA   Yang X., Lee W.H., Sobott F., Papagrigoriou E., Robinson C.V.,
RA   Grossmann J.G., Sundstroem M., Doyle D.A., Elkins J.M.;
RT   "Structural basis for protein-protein interactions in the 14-3-3
RT   protein family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:17237-17242(2006).
CC   -!- FUNCTION: Adapter protein implicated in the regulation of a large
CC       spectrum of both general and specialized signaling pathways. Binds
CC       to a large number of partners, usually by recognition of a
CC       phosphoserine or phosphothreonine motif. Binding generally results
CC       in the modulation of the activity of the binding partner.
CC   -!- SUBUNIT: Homodimer. Heterodimerizes with YWHAZ. Interacts with
CC       NDEL1, ARHGEF28 and TIAM2 (By similarity). Interacts with HCV core
CC       protein. Interacts with ABL1 (phosphorylated form); the
CC       interaction retains it in the cytoplasm. Weakly interacts with
CC       CDKN1B. Interacts with GAB2. Interacts with phosphorylated GRB10.
CC       Interacts with PKA-phosphorylated AANAT. Interacts with the
CC       phosphorylated (by AKT1) form of SRPK2.
CC   -!- INTERACTION:
CC       O00257-3:CBX4; NbExp=2; IntAct=EBI-356498, EBI-4392727;
CC       O94921:CDK14; NbExp=3; IntAct=EBI-356498, EBI-1043945;
CC       Q9UKT5:FBXO4; NbExp=5; IntAct=EBI-356498, EBI-960409;
CC       Q14678-2:KANK1; NbExp=3; IntAct=EBI-356498, EBI-6173812;
CC       Q5S007:LRRK2; NbExp=3; IntAct=EBI-356498, EBI-5323863;
CC       P61981:YWHAG; NbExp=4; IntAct=EBI-356498, EBI-359832;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Melanosome.
CC       Note=Identified by mass spectrometry in melanosome fractions from
CC       stage I to stage IV.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P62258-1; Sequence=Displayed;
CC       Name=SV;
CC         IsoId=P62258-2; Sequence=VSP_040621;
CC         Note=Unable to dimerize with YWHAZ;
CC   -!- SIMILARITY: Belongs to the 14-3-3 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U20972; AAC50175.1; -; mRNA.
DR   EMBL; U54778; AAC50710.1; -; mRNA.
DR   EMBL; U43399; AAC50625.1; -; mRNA.
DR   EMBL; U43430; AAD00026.1; -; mRNA.
DR   EMBL; U28936; AAA75301.1; -; mRNA.
DR   EMBL; AB017103; BAA32538.1; -; Genomic_DNA.
DR   EMBL; AY883089; AAX68683.1; -; mRNA.
DR   EMBL; AK128785; BAG54733.1; -; mRNA.
DR   EMBL; AK295260; BAG58249.1; -; mRNA.
DR   EMBL; AK316185; BAH14556.1; -; mRNA.
DR   EMBL; BT007161; AAP35825.1; -; mRNA.
DR   EMBL; CH471108; EAW90628.1; -; Genomic_DNA.
DR   EMBL; CH471108; EAW90629.1; -; Genomic_DNA.
DR   EMBL; BC000179; AAH00179.1; -; mRNA.
DR   EMBL; BC001440; AAH01440.1; -; mRNA.
DR   IPI; IPI00000816; -.
DR   IPI; IPI00974544; -.
DR   PIR; A61235; A61235.
DR   PIR; I38947; I38947.
DR   RefSeq; NP_006752.1; NM_006761.4.
DR   UniGene; Hs.513851; -.
DR   PDB; 2BR9; X-ray; 1.75 A; A=1-233.
DR   PDB; 3UAL; X-ray; 1.80 A; A=1-232.
DR   PDB; 3UBW; X-ray; 1.90 A; A=1-234.
DR   PDBsum; 2BR9; -.
DR   PDBsum; 3UAL; -.
DR   PDBsum; 3UBW; -.
DR   ProteinModelPortal; P62258; -.
DR   SMR; P62258; 3-232.
DR   DIP; DIP-36676N; -.
DR   IntAct; P62258; 97.
DR   MINT; MINT-4998623; -.
DR   STRING; P62258; -.
DR   PhosphoSite; P62258; -.
DR   DMDM; 51702210; -.
DR   OGP; P42655; -.
DR   UCD-2DPAGE; P62258; -.
DR   PaxDb; P62258; -.
DR   PeptideAtlas; P62258; -.
DR   PRIDE; P62258; -.
DR   DNASU; 7531; -.
DR   Ensembl; ENST00000264335; ENSP00000264335; ENSG00000108953.
DR   Ensembl; ENST00000571732; ENSP00000461762; ENSG00000108953.
DR   GeneID; 7531; -.
DR   KEGG; hsa:7531; -.
DR   UCSC; uc002fsj.3; human.
DR   CTD; 7531; -.
DR   GeneCards; GC17M001247; -.
DR   H-InvDB; HIX0013751; -.
DR   H-InvDB; HIX0030006; -.
DR   HGNC; HGNC:12851; YWHAE.
DR   HPA; CAB016200; -.
DR   HPA; CAB021109; -.
DR   HPA; CAB047350; -.
DR   HPA; HPA008445; -.
DR   MIM; 605066; gene.
DR   neXtProt; NX_P62258; -.
DR   Orphanet; 217385; 17p13.3 microduplication syndrome.
DR   PharmGKB; PA37440; -.
DR   eggNOG; COG5040; -.
DR   HOVERGEN; HBG050423; -.
DR   InParanoid; P62258; -.
DR   KO; K06630; -.
DR   OMA; KESALIM; -.
DR   OrthoDB; EOG4HHP34; -.
DR   PhylomeDB; P62258; -.
DR   Pathway_Interaction_DB; a6b1_a6b4_integrin_pathway; a6b1 and a6b4 Integrin signaling.
DR   Pathway_Interaction_DB; pi3kciaktpathway; Class I PI3K signaling events mediated by Akt.
DR   Pathway_Interaction_DB; foxopathway; FoxO family signaling.
DR   Pathway_Interaction_DB; igf1_pathway; IGF1 pathway.
DR   Pathway_Interaction_DB; insulin_glucose_pathway; Insulin-mediated glucose transport.
DR   Pathway_Interaction_DB; lis1pathway; Lissencephaly gene (LIS1) in neuronal migration and development.
DR   Pathway_Interaction_DB; p38_mk2pathway; p38 signaling mediated by MAPKAP kinases.
DR   Pathway_Interaction_DB; p75ntrpathway; p75(NTR)-mediated signaling.
DR   Pathway_Interaction_DB; telomerasepathway; Regulation of Telomerase.
DR   Pathway_Interaction_DB; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes.
DR   Pathway_Interaction_DB; hdac_classii_pathway; Signaling events mediated by HDAC Class II.
DR   Pathway_Interaction_DB; tgfbrpathway; TGF-beta receptor signaling.
DR   Pathway_Interaction_DB; pi3kplctrkpathway; Trk receptor signaling mediated by PI3K and PLC-gamma.
DR   Reactome; REACT_111102; Signal Transduction.
DR   Reactome; REACT_11123; Membrane Trafficking.
DR   Reactome; REACT_115566; Cell Cycle.
DR   EvolutionaryTrace; P62258; -.
DR   GenomeRNAi; 7531; -.
DR   NextBio; 29461; -.
DR   PMAP-CutDB; P62258; -.
DR   ArrayExpress; P62258; -.
DR   Bgee; P62258; -.
DR   CleanEx; HS_YWHAE; -.
DR   Genevestigator; P62258; -.
DR   GermOnline; ENSG00000108953; Homo sapiens.
DR   GO; GO:0033267; C:axon part; IEA:Compara.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005871; C:kinesin complex; IEA:Compara.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IEA:Compara.
DR   GO; GO:0006915; P:apoptotic process; TAS:Reactome.
DR   GO; GO:0021987; P:cerebral cortex development; IEA:Compara.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0035329; P:hippo signaling cascade; TAS:Reactome.
DR   GO; GO:0021766; P:hippocampus development; IEA:Compara.
DR   GO; GO:0035308; P:negative regulation of protein dephosphorylation; IEA:Compara.
DR   GO; GO:0048011; P:nerve growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0001764; P:neuron migration; IEA:Compara.
DR   GO; GO:0006605; P:protein targeting; IEA:Compara.
DR   GO; GO:0019048; P:virus-host interaction; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.190.20; 14-3-3; 1.
DR   InterPro; IPR000308; 14-3-3.
DR   InterPro; IPR023409; 14-3-3_CS.
DR   InterPro; IPR023410; 14-3-3_domain.
DR   PANTHER; PTHR18860; PTHR18860; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   SMART; SM00101; 14_3_3; 1.
DR   SUPFAM; SSF48445; 14-3-3; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Host-virus interaction;
KW   Phosphoprotein; Reference proteome.
FT   CHAIN         1    255       14-3-3 protein epsilon.
FT                                /FTId=PRO_0000058618.
FT   SITE         57     57       Interaction with phosphoserine on
FT                                interacting protein.
FT   SITE        130    130       Interaction with phosphoserine on
FT                                interacting protein.
FT   MOD_RES       1      1       N-acetylmethionine.
FT   MOD_RES      38     38       Phosphothreonine.
FT   MOD_RES      50     50       N6-acetyllysine.
FT   MOD_RES      69     69       N6-acetyllysine.
FT   MOD_RES     118    118       N6-acetyllysine.
FT   MOD_RES     123    123       N6-acetyllysine.
FT   MOD_RES     210    210       Phosphoserine.
FT   VAR_SEQ       1     22       Missing (in isoform SV).
FT                                /FTId=VSP_040621.
FT   CONFLICT    106    107       KH -> NY (in Ref. 13; AA sequence).
FT   CONFLICT    143    143       E -> F (in Ref. 13; AA sequence).
FT   CONFLICT    148    148       S -> T (in Ref. 13; AA sequence).
FT   HELIX         4     17
FT   HELIX        20     31
FT   HELIX        39     73
FT   HELIX        76    106
FT   HELIX       108    111
FT   HELIX       115    135
FT   HELIX       138    162
FT   HELIX       168    183
FT   HELIX       188    204
FT   HELIX       205    208
FT   TURN        211    213
FT   HELIX       214    231
SQ   SEQUENCE   255 AA;  29174 MW;  07817CCBD1F75B26 CRC64;
     MDDREDLVYQ AKLAEQAERY DEMVESMKKV AGMDVELTVE ERNLLSVAYK NVIGARRASW
     RIISSIEQKE ENKGGEDKLK MIREYRQMVE TELKLICCDI LDVLDKHLIP AANTGESKVF
     YYKMKGDYHR YLAEFATGND RKEAAENSLV AYKAASDIAM TELPPTHPIR LGLALNFSVF
     YYEILNSPDR ACRLAKAAFD DAIAELDTLS EESYKDSTLI MQLLRDNLTL WTSDMQGDGE
     EQNKEALQDV EDENQ
//
ID   ARSF_HUMAN              Reviewed;         590 AA.
AC   P54793; Q8TCC5;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   22-SEP-2009, sequence version 4.
DT   28-NOV-2012, entry version 101.
DE   RecName: Full=Arylsulfatase F;
DE            Short=ASF;
DE            EC=3.1.6.-;
DE   Flags: Precursor;
GN   Name=ARSF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT TYR-527.
RC   TISSUE=Fetal brain;
RX   MEDLINE=97336043; PubMed=9192838; DOI=10.1006/geno.1997.4716;
RA   Puca A.A., Zollo M., Repetto M., Andolfi G., Guffanti A., Simon G.,
RA   Ballabio A., Franco B.;
RT   "Identification by shotgun sequencing, genomic organization, and
RT   functional analysis of a fourth arylsulfatase gene (ARSF) from the
RT   Xp22.3 region.";
RL   Genomics 42:192-199(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT TYR-527.
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 369-422.
RC   TISSUE=Kidney;
RX   MEDLINE=95236447; PubMed=7720070; DOI=10.1016/0092-8674(95)90367-4;
RA   Franco B., Meroni G., Parenti G., Levilliers J., Bernard L.,
RA   Gebbia M., Cox L., Maroteaux P., Sheffield L., Rappold G.A.,
RA   Andria G., Petit C., Ballabio A.;
RT   "A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia
RT   punctata (CDPX) and implications for warfarin embryopathy.";
RL   Cell 81:15-25(1995).
CC   -!- COFACTOR: Binds 1 calcium ion per subunit (By similarity).
CC   -!- ENZYME REGULATION: Not inhibited by DHEAS or warfarin.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 8;
CC   -!- SUBCELLULAR LOCATION: Secreted (Potential).
CC   -!- PTM: The conversion to 3-oxoalanine (also known as C-
CC       formylglycine, FGly), of a serine or cysteine residue in
CC       prokaryotes and of a cysteine residue in eukaryotes, is critical
CC       for catalytic activity (By similarity).
CC   -!- SIMILARITY: Belongs to the sulfatase family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X97868; CAA66462.1; -; mRNA.
DR   EMBL; AC112653; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC022389; AAH22389.1; -; mRNA.
DR   IPI; IPI00008405; -.
DR   PIR; A56217; A56217.
DR   RefSeq; NP_001188467.1; NM_001201538.1.
DR   RefSeq; NP_001188468.1; NM_001201539.1.
DR   RefSeq; NP_004033.2; NM_004042.4.
DR   UniGene; Hs.101674; -.
DR   ProteinModelPortal; P54793; -.
DR   SMR; P54793; 26-577.
DR   IntAct; P54793; 1.
DR   STRING; P54793; -.
DR   PhosphoSite; P54793; -.
DR   DMDM; 259016386; -.
DR   PaxDb; P54793; -.
DR   PRIDE; P54793; -.
DR   Ensembl; ENST00000359361; ENSP00000352319; ENSG00000062096.
DR   Ensembl; ENST00000381127; ENSP00000370519; ENSG00000062096.
DR   Ensembl; ENST00000537104; ENSP00000445594; ENSG00000062096.
DR   GeneID; 416; -.
DR   KEGG; hsa:416; -.
DR   UCSC; uc004cre.2; human.
DR   CTD; 416; -.
DR   GeneCards; GC0XP002978; -.
DR   H-InvDB; HIX0016636; -.
DR   HGNC; HGNC:721; ARSF.
DR   HPA; HPA000549; -.
DR   MIM; 300003; gene.
DR   neXtProt; NX_P54793; -.
DR   PharmGKB; PA25012; -.
DR   eggNOG; COG3119; -.
DR   HOGENOM; HOG000135352; -.
DR   HOVERGEN; HBG004283; -.
DR   InParanoid; P54793; -.
DR   KO; K12374; -.
DR   OMA; IMVKEAI; -.
DR   OrthoDB; EOG4V4379; -.
DR   PhylomeDB; P54793; -.
DR   Reactome; REACT_111217; Metabolism.
DR   Reactome; REACT_17015; Metabolism of proteins.
DR   GenomeRNAi; 416; -.
DR   NextBio; 1759; -.
DR   ArrayExpress; P54793; -.
DR   Bgee; P54793; -.
DR   CleanEx; HS_ARSF; -.
DR   Genevestigator; P54793; -.
DR   GermOnline; ENSG00000062096; Homo sapiens.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0004065; F:arylsulfatase activity; TAS:ProtInc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome.
DR   GO; GO:0006644; P:phospholipid metabolic process; TAS:Reactome.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0044281; P:small molecule metabolic process; TAS:Reactome.
DR   Gene3D; 3.40.720.10; Alk_phosphtse; 2.
DR   InterPro; IPR017849; Alkaline_Pase-like_a/b/a.
DR   InterPro; IPR017850; Alkaline_phosphatase_core.
DR   InterPro; IPR000917; Sulfatase.
DR   InterPro; IPR024607; Sulfatase_CS.
DR   Pfam; PF00884; Sulfatase; 1.
DR   SUPFAM; SSF53649; Alkaline_phosphatase_core; 1.
DR   PROSITE; PS00523; SULFATASE_1; 1.
DR   PROSITE; PS00149; SULFATASE_2; 1.
PE   1: Evidence at protein level;
KW   Calcium; Complete proteome; Glycoprotein; Hydrolase; Metal-binding;
KW   Polymorphism; Reference proteome; Secreted; Signal.
FT   SIGNAL        1     22       Potential.
FT   CHAIN        23    590       Arylsulfatase F.
FT                                /FTId=PRO_0000033427.
FT   ACT_SITE    139    139       By similarity.
FT   METAL        38     38       Calcium (By similarity).
FT   METAL        39     39       Calcium (By similarity).
FT   METAL        78     78       Calcium; via 3-oxoalanine (By
FT                                similarity).
FT   METAL       345    345       Calcium (By similarity).
FT   METAL       346    346       Calcium (By similarity).
FT   BINDING     137    137       Substrate (By similarity).
FT   BINDING     293    293       Substrate (By similarity).
FT   BINDING     370    370       Substrate (By similarity).
FT   MOD_RES      78     78       3-oxoalanine (Cys) (By similarity).
FT   CARBOHYD     50     50       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    117    117       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    336    336       N-linked (GlcNAc...) (Potential).
FT   VARIANT     527    527       H -> Y (in dbSNP:rs1052638).
FT                                /FTId=VAR_058846.
FT   CONFLICT     20     29       CQAHRVHDDK -> WPGHTGCMTTR (in Ref. 1;
FT                                CAA66462).
SQ   SEQUENCE   590 AA;  65940 MW;  EA9B7289040AE79A CRC64;
     MRPRRPLVFM SLVCALLNTC QAHRVHDDKP NIVLIMVDDL GIGDLGCYGN DTMRTPHIDR
     LAREGVRLTQ HISAASLCSP SRSAFLTGRY PIRSGMVSSG NRRVIQNLAV PAGLPLNETT
     LAALLKKQGY STGLIGKWHQ GLNCDSRSDQ CHHPYNYGFD YYYGMPFTLV DSCWPDPSRN
     TELAFESQLW LCVQLVAIAI LTLTFGKLSG WVSVPWLLIF SMILFIFLLG YAWFSSHTSP
     LYWDCLLMRG HEITEQPMKA ERAGSIMVKE AISFLERHSK ETFLLFFSFL HVHTPLPTTD
     DFTGTSKHGL YGDNVEEMDS MVGKILDAID DFGLRNNTLV YFTSDHGGHL EARRGHAQLG
     GWNGIYKGGK GMGGWEGGIR VPGIVRWPGK VPAGRLIKEP TSLMDILPTV ASVSGGSLPQ
     DRVIDGRDLM PLLQGNVRHS EHEFLFHYCG SYLHAVRWIP KDDSGSVWKA HYVTPVFQPP
     ASGGCYVTSL CRCFGEQVTY HNPPLLFDLS RDPSESTPLT PATEPLHDFV IKKVANALKE
     HQETIVPVTY QLSELNQGRT WLKPCCGVFP FCLCDKEEEV SQPRGPNEKR
//
ID   ARSG_HUMAN              Reviewed;         525 AA.
AC   Q96EG1; Q6UXF2; Q9Y2K4;
DT   11-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   28-NOV-2012, entry version 88.
DE   RecName: Full=Arylsulfatase G;
DE            Short=ASG;
DE            EC=3.1.6.-;
DE   Flags: Precursor;
GN   Name=ARSG; Synonyms=KIAA1001; ORFNames=UNQ839/PRO1777;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   MEDLINE=99246063; PubMed=10231032; DOI=10.1093/dnares/6.1.63;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M.,
RA   Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:63-70(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   MEDLINE=22887296; PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND GLYCOSYLATION.
RX   PubMed=12461688; DOI=10.1038/sj.ejhg.5200887;
RA   Ferrante P., Messali S., Meroni G., Ballabio A.;
RT   "Molecular and biochemical characterisation of a novel sulphatase
RT   gene: arylsulfatase G (ARSG).";
RL   Eur. J. Hum. Genet. 10:813-818(2002).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, OXOALANINE AT
RP   CYS-84, GLYCOSYLATION, BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS
RP   OF CYS-84 AND ALA-501.
RX   PubMed=18283100; DOI=10.1074/jbc.M709917200;
RA   Frese M.A., Schulz S., Dierks T.;
RT   "Arylsulfatase G, a novel lysosomal sulfatase.";
RL   J. Biol. Chem. 283:11388-11395(2008).
CC   -!- FUNCTION: Displays arylsulfatase activity at acidic pH with
CC       pseudosubstrates, such as p-nitrocatechol sulfate and also, but
CC       with lower activity, p-nitrophenyl sulfate and 4-
CC       methylumbelliferyl sulfate.
CC   -!- COFACTOR: Binds 1 calcium ion per subunit (By similarity).
CC   -!- ENZYME REGULATION: Inhibited by phosphate. The phosphate forms a
CC       covalent bond with the active site 3-oxoalanine.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=4.2 mM for p-nitrocatechol sulfate;
CC         Vmax=63.5 umol/min/mg enzyme toward p-nitrocatechol sulfate;
CC       pH dependence:
CC         Optimum pH is 5.4;
CC       Temperature dependence:
CC         Most efficient at 45-50 degrees Celsius;
CC   -!- SUBCELLULAR LOCATION: Lysosome. Note=Previously observed
CC       endoplasmic reticulum localization is most likely due to
CC       folding/maturation problems for overexpressed proteins.
CC   -!- TISSUE SPECIFICITY: Widely expressed, with very low expression in
CC       brain, lung, heart and skeletal muscle.
CC   -!- PTM: N-glycosylated.
CC   -!- PTM: The conversion to 3-oxoalanine (also known as C-
CC       formylglycine, FGly), of a serine or cysteine residue in
CC       prokaryotes and of a cysteine residue in eukaryotes, is critical
CC       for catalytic activity (By similarity).
CC   -!- PTM: Glycosylated.
CC   -!- SIMILARITY: Belongs to the sulfatase family.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA76845.2; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB023218; BAA76845.2; ALT_INIT; mRNA.
DR   EMBL; AY358380; AAQ88746.1; -; mRNA.
DR   EMBL; BC012375; AAH12375.1; -; mRNA.
DR   IPI; IPI00402293; -.
DR   RefSeq; NP_001254656.1; NM_001267727.1.
DR   RefSeq; NP_055775.2; NM_014960.4.
DR   UniGene; Hs.437249; -.
DR   ProteinModelPortal; Q96EG1; -.
DR   SMR; Q96EG1; 34-523.
DR   STRING; Q96EG1; -.
DR   DMDM; 74731559; -.
DR   PaxDb; Q96EG1; -.
DR   PeptideAtlas; Q96EG1; -.
DR   PRIDE; Q96EG1; -.
DR   Ensembl; ENST00000448504; ENSP00000407193; ENSG00000141337.
DR   Ensembl; ENST00000570630; ENSP00000459720; ENSG00000263074.
DR   GeneID; 22901; -.
DR   KEGG; hsa:22901; -.
DR   UCSC; uc002jhc.2; human.
DR   CTD; 22901; -.
DR   GeneCards; GC17P066255; -.
DR   HGNC; HGNC:24102; ARSG.
DR   HPA; HPA023245; -.
DR   HPA; HPA023285; -.
DR   MIM; 610008; gene.
DR   neXtProt; NX_Q96EG1; -.
DR   PharmGKB; PA143485307; -.
DR   eggNOG; COG3119; -.
DR   HOGENOM; HOG000135352; -.
DR   HOVERGEN; HBG004283; -.
DR   InParanoid; Q96EG1; -.
DR   KO; K12381; -.
DR   OMA; VTPCCNP; -.
DR   OrthoDB; EOG4J9MZJ; -.
DR   PhylomeDB; Q96EG1; -.
DR   Reactome; REACT_111217; Metabolism.
DR   Reactome; REACT_17015; Metabolism of proteins.
DR   GenomeRNAi; 22901; -.
DR   NextBio; 43535; -.
DR   ArrayExpress; Q96EG1; -.
DR   CleanEx; HS_ARSG; -.
DR   Genevestigator; Q96EG1; -.
DR   GermOnline; ENSG00000141337; Homo sapiens.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005764; C:lysosome; IDA:UniProtKB.
DR   GO; GO:0004065; F:arylsulfatase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome.
DR   GO; GO:0006644; P:phospholipid metabolic process; TAS:Reactome.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0044281; P:small molecule metabolic process; TAS:Reactome.
DR   GO; GO:0006790; P:sulfur compound metabolic process; IDA:UniProtKB.
DR   Gene3D; 3.40.720.10; Alk_phosphtse; 1.
DR   InterPro; IPR017849; Alkaline_Pase-like_a/b/a.
DR   InterPro; IPR017850; Alkaline_phosphatase_core.
DR   InterPro; IPR000917; Sulfatase.
DR   InterPro; IPR024607; Sulfatase_CS.
DR   Pfam; PF00884; Sulfatase; 1.
DR   SUPFAM; SSF53649; Alkaline_phosphatase_core; 1.
DR   PROSITE; PS00523; SULFATASE_1; 1.
DR   PROSITE; PS00149; SULFATASE_2; 1.
PE   1: Evidence at protein level;
KW   Calcium; Complete proteome; Glycoprotein; Hydrolase; Lysosome;
KW   Metal-binding; Polymorphism; Reference proteome; Signal.
FT   SIGNAL        1     16       Potential.
FT   CHAIN        17    525       Arylsulfatase G.
FT                                /FTId=PRO_0000042215.
FT   ACT_SITE    139    139       By similarity.
FT   METAL        44     44       Calcium (By similarity).
FT   METAL        45     45       Calcium (By similarity).
FT   METAL        84     84       Calcium; via 3-oxoalanine (By
FT                                similarity).
FT   METAL       302    302       Calcium (By similarity).
FT   METAL       303    303       Calcium (By similarity).
FT   BINDING     137    137       Substrate (By similarity).
FT   BINDING     162    162       Substrate (By similarity).
FT   BINDING     251    251       Substrate (By similarity).
FT   MOD_RES      84     84       3-oxoalanine (Cys).
FT   CARBOHYD    117    117       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    215    215       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    356    356       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    497    497       N-linked (GlcNAc...) (Potential).
FT   VARIANT      11     11       A -> V (in dbSNP:rs8074806).
FT                                /FTId=VAR_052511.
FT   VARIANT     236    236       T -> S (in dbSNP:rs1558876).
FT                                /FTId=VAR_052512.
FT   VARIANT     274    274       W -> R (in dbSNP:rs1558878).
FT                                /FTId=VAR_052513.
FT   VARIANT     385    385       R -> H (in dbSNP:rs9972951).
FT                                /FTId=VAR_052514.
FT   MUTAGEN      84     84       C->A: No sulfatase activity.
FT   MUTAGEN     501    501       A->P: Decrease of sulfatase activity.
FT   CONFLICT    444    445       TG -> MV (in Ref. 2; AAQ88746).
FT   CONFLICT    501    501       A -> P (in Ref. 1; BAA76845).
SQ   SEQUENCE   525 AA;  57061 MW;  ADAB673A02B25754 CRC64;
     MGWLFLKVLL AGVSFSGFLY PLVDFCISGK TRGQKPNFVI ILADDMGWGD LGANWAETKD
     TANLDKMASE GMRFVDFHAA ASTCSPSRAS LLTGRLGLRN GVTRNFAVTS VGGLPLNETT
     LAEVLQQAGY VTGIIGKWHL GHHGSYHPNF RGFDYYFGIP YSHDMGCTDT PGYNHPPCPA
     CPQGDGPSRN LQRDCYTDVA LPLYENLNIV EQPVNLSSLA QKYAEKATQF IQRASTSGRP
     FLLYVALAHM HVPLPVTQLP AAPRGRSLYG AGLWEMDSLV GQIKDKVDHT VKENTFLWFT
     GDNGPWAQKC ELAGSVGPFT GFWQTRQGGS PAKQTTWEGG HRVPALAYWP GRVPVNVTST
     ALLSVLDIFP TVVALAQASL PQGRRFDGVD VSEVLFGRSQ PGHRVLFHPN SGAAGEFGAL
     QTVRLERYKA FYITGGARAC DGSTGPELQH KFPLIFNLED DTAEAVPLER GGAEYQAVLP
     EVRKVLADVL QDIANDNISS ADYTQDPSVT PCCNPYQIAC RCQAA
//
ID   ATN1_HUMAN              Reviewed;        1190 AA.
AC   P54259; Q99495; Q99621; Q9UEK7;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 3.
DT   28-NOV-2012, entry version 120.
DE   RecName: Full=Atrophin-1;
DE   AltName: Full=Dentatorubral-pallidoluysian atrophy protein;
GN   Name=ATN1; Synonyms=D12S755E, DRPLA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANT
RP   484-GLN--GLN-488 DEL.
RC   TISSUE=Brain;
RX   MEDLINE=95144175; PubMed=7842016; DOI=10.1038/ng1094-177;
RA   Nagafuchi S., Yanagisawa H., Ohsaki E., Shirayama T., Tadokoro K.,
RA   Inoue T., Yamada M.;
RT   "Structure and expression of the gene responsible for the triplet
RT   repeat disorder, dentatorubral and pallidoluysian atrophy (DRPLA).";
RL   Nat. Genet. 8:177-182(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANT
RP   484-GLN--GLN-488 DEL.
RC   TISSUE=Brain;
RX   MEDLINE=96026098; PubMed=7485154;
RA   Onodera O., Oyake M., Takano H., Ikeuchi T., Igarashi S., Tsuji S.;
RT   "Molecular cloning of a full-length cDNA for dentatorubral-
RT   pallidoluysian atrophy and regional expressions of the expanded
RT   alleles in the CNS.";
RL   Am. J. Hum. Genet. 57:1050-1060(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANTS ILE-339
RP   AND 484-GLN--GLN-488 DEL.
RX   MEDLINE=96262314; PubMed=8965642; DOI=10.1016/0169-328X(95)00241-J;
RA   Margolis R.L., Li S.-H., Young W.S., Wagster M.V., Stine O.C.,
RA   Kidwai A.S., Ashworth R.G., Ross C.A.;
RT   "DRPLA gene (atrophin-1) sequence and mRNA expression in human
RT   brain.";
RL   Brain Res. Mol. Brain Res. 36:219-226(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND POLYMORPHISM OF POLY-GLN
RP   REGION.
RC   TISSUE=Brain;
RX   MEDLINE=97228904; PubMed=9074930;
RA   Ansari-Lari M.A., Shen Y., Muzny D.M., Lee W., Gibbs R.A.;
RT   "Large-scale sequencing in human chromosome 12p13: experimental and
RT   computational gene structure determination.";
RL   Genome Res. 7:268-280(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-76.
RX   MEDLINE=97005364; PubMed=8852663; DOI=10.1093/hmg/5.3.373;
RA   Yanagisawa H., Fujii K., Nagafuchi S., Nakahori Y., Nakagome Y.,
RA   Akane A., Nakamura M., Sano A., Komure O., Kondo I., Jin D.K.,
RA   Soerensen S.A., Potter N.T., Young S.R., Nakamura K., Nukina N.,
RA   Nagao Y., Tadokoro K., Okuyama T., Miyashita T., Inoue T.,
RA   Kanazawa I., Yamada M.;
RT   "A unique origin and multistep process for the generation of expanded
RT   DRPLA triplet repeats.";
RL   Hum. Mol. Genet. 5:373-379(1996).
RN   [6]
RP   INVOLVEMENT IN HRS.
RX   PubMed=7951323; DOI=10.1038/ng0894-521;
RA   Burke J.R., Wingfield M.S., Lewis K.E., Roses A.D., Lee J.E.,
RA   Hulette C., Pericak-Vance M.A., Vance J.M.;
RT   "The Haw River syndrome: dentatorubropallidoluysian atrophy (DRPLA) in
RT   an African-American family.";
RL   Nat. Genet. 7:521-524(1994).
RN   [7]
RP   PROTEOLYTIC PROCESSING.
RX   PubMed=9361003; DOI=10.1074/jbc.272.46.29238;
RA   Miyashita T., Okamura-Oho Y., Mito Y., Nagafuchi S., Yamada M.;
RT   "Dentatorubral pallidoluysian atrophy (DRPLA) protein is cleaved by
RT   caspase-3 during apoptosis.";
RL   J. Biol. Chem. 272:29238-29242(1997).
RN   [8]
RP   INTERACTION WITH WWP1; WWP2 AND WWP3.
RX   MEDLINE=98313405; PubMed=9647693; DOI=10.1006/mcne.1998.0677;
RA   Wood J.D., Yuan J., Margolis R.L., Colomer V., Duan K., Kushi J.,
RA   Kaminsky Z., Kleiderlein J.J. Jr., Sharp A.H., Ross C.A.;
RT   "Atrophin-1, the DRPLA gene product, interacts with two families of WW
RT   domain-containing proteins.";
RL   Mol. Cell. Neurosci. 11:149-160(1998).
RN   [9]
RP   INTERACTION WITH BAIAP2, AND SUBCELLULAR LOCATION.
RX   MEDLINE=99265910; PubMed=10332026; DOI=10.1093/hmg/8.6.947;
RA   Okamura-Oho Y., Miyashita T., Ohmi K., Yamada M.;
RT   "Dentatorubral-pallidoluysian atrophy protein interacts through a
RT   proline-rich region near polyglutamine with the SH3 domain of an
RT   insulin receptor tyrosine kinase substrate.";
RL   Hum. Mol. Genet. 8:947-957(1999).
RN   [10]
RP   CLEAVAGE AT ASP-109, FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS
RP   OF ASP-109.
RX   PubMed=10085113; DOI=10.1074/jbc.274.13.8730;
RA   Ellerby L.M., Andrusiak R.L., Wellington C.L., Hackam A.S.,
RA   Propp S.S., Wood J.D., Sharp A.H., Margolis R.L., Ross C.A.,
RA   Salvesen G.S., Hayden M.R., Bredesen D.E.;
RT   "Cleavage of atrophin-1 at caspase site aspartic acid 109 modulates
RT   cytotoxicity.";
RL   J. Biol. Chem. 274:8730-8736(1999).
RN   [11]
RP   INTERACTION WITH RERE.
RX   MEDLINE=20275632; PubMed=10814707; DOI=10.1093/hmg/9.9.1433;
RA   Yanagisawa H., Bundo M., Miyashita T., Okamura-Oho Y., Tadokoro K.,
RA   Tokunaga K., Yamada M.;
RT   "Protein binding of a DRPLA family through arginine-glutamic acid
RT   dipeptide repeats is enhanced by extended polyglutamine.";
RL   Hum. Mol. Genet. 9:1433-1442(2000).
RN   [12]
RP   INTERACTION WITH MTG8, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=10973986; DOI=10.1083/jcb.150.5.939;
RA   Wood J.D., Nucifora F.C. Jr., Duan K., Zhang C., Wang J., Kim Y.,
RA   Schilling G., Sacchi N., Liu J.M., Ross C.A.;
RT   "Atrophin-1, the dentato-rubral and pallido-luysian atrophy gene
RT   product, interacts with ETO/MTG8 in the nuclear matrix and represses
RT   transcription.";
RL   J. Cell Biol. 150:939-948(2000).
RN   [13]
RP   PHOSPHORYLATION AT SER-739.
RX   PubMed=12812981; DOI=10.1093/hmg/ddg168;
RA   Okamura-Oho Y., Miyashita T., Nagao K., Shima S., Ogata Y., Katada T.,
RA   Nishina H., Yamada M.;
RT   "Dentatorubral-pallidoluysian atrophy protein is phosphorylated by c-
RT   Jun NH2-terminal kinase.";
RL   Hum. Mol. Genet. 12:1535-1542(2003).
RN   [14]
RP   PROTEOLYTIC PROCESSING, NUCLEAR LOCALIZATION SIGNAL, NUCLEAR EXPORT
RP   SIGNAL, AND SUBCELLULAR LOCATION.
RX   PubMed=12464607; DOI=10.1074/jbc.M211224200;
RA   Nucifora F.C. Jr., Ellerby L.M., Wellington C.L., Wood J.D.,
RA   Herring W.J., Sawa A., Hayden M.R., Dawson V.L., Dawson T.M.,
RA   Ross C.A.;
RT   "Nuclear localization of a non-caspase truncation product of atrophin-
RT   1, with an expanded polyglutamine repeat, increases cellular
RT   toxicity.";
RL   J. Biol. Chem. 278:13047-13055(2003).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-34; SER-77; SER-101;
RP   SER-107; SER-112; SER-119; SER-632; SER-645; THR-653; SER-661;
RP   THR-669; SER-746 AND SER-748, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=15302935; DOI=10.1073/pnas.0404720101;
RA   Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,
RA   Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
RT   "Large-scale characterization of HeLa cell nuclear phosphoproteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77; SER-79; SER-101;
RP   SER-103; SER-107; SER-739; SER-746 AND SER-748, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77; SER-79; SER-101;
RP   SER-103; SER-107; THR-651; THR-653; SER-661; TYR-734; SER-746 AND
RP   SER-748, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [18]
RP   INTERACTION WITH FAT1.
RX   PubMed=19131340; DOI=10.1074/jbc.M809333200;
RA   Hou R., Sibinga N.E.;
RT   "Atrophin proteins interact with the Fat1 cadherin and regulate
RT   migration and orientation in vascular smooth muscle cells.";
RL   J. Biol. Chem. 284:6955-6965(2009).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-641, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-101, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [21]
RP   PROTEOLYTIC PROCESSING, AND SUBCELLULAR LOCATION.
RX   PubMed=20977674; DOI=10.1111/j.1742-4658.2010.07893.x;
RA   Suzuki Y., Nakayama K., Hashimoto N., Yazawa I.;
RT   "Proteolytic processing regulates pathological accumulation in
RT   dentatorubral-pallidoluysian atrophy.";
RL   FEBS J. 277:4873-4887(2010).
CC   -!- FUNCTION: Transcriptional corepressor. Recruits NR2E1 to repress
CC       transcription. Promotes vascular smooth cell (VSMC) migration and
CC       orientation (By similarity). Corepressor of MTG8 transcriptional
CC       repression. Has some intrinsic repression activity which is
CC       independent of the number of poly-Asn (polyQ) repeats.
CC   -!- SUBUNIT: Interacts with NR2E1; the interaction represses the
CC       transcriptional activity of NR2E1. Interacts (via its N-terminus)
CC       with FAT1 (via a C-terminus domain) (By similarity). Interacts
CC       with BAIAP2, WWP1, WWP2, WWP3 and RERE. Interacts (via its N-
CC       terminus) with MTG8; the interaction enhances transcriptional
CC       repression of MTG8.
CC   -!- INTERACTION:
CC       Q12805:EFEMP1; NbExp=3; IntAct=EBI-945980, EBI-536772;
CC       O95967:EFEMP2; NbExp=3; IntAct=EBI-945980, EBI-743414;
CC       Q9HAU0:PLEKHA5; NbExp=2; IntAct=EBI-945980, EBI-945934;
CC       P61289:PSME3; NbExp=3; IntAct=EBI-945980, EBI-355546;
CC       Q9NWB1:RBFOX1; NbExp=2; IntAct=EBI-945980, EBI-945906;
CC       Q9P2R6:RERE; NbExp=3; IntAct=EBI-945980, EBI-948076;
CC       Q15654:TRIP6; NbExp=2; IntAct=EBI-945980, EBI-742327;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm, perinuclear region. Cell
CC       junction (By similarity). Note=Shuttles between nucleus and
CC       cytoplasm. Colocalizes with FAT1 in the perinuclear area, at cell-
CC       cell junctions and leading edges of cells (By similarity).
CC       Colocalizes with MTG8 in discrete nuclear dots. Proteolytic
CC       fragment F1 appears to remain in nucleus. Fragment F2 is exported
CC       into the cytoplasm. Fragment F2 from mutant sequences with longer
CC       poly-Asn (polyQ) tracts are additionally located to the
CC       cytoplasmic membrane and to certain organelles.
CC   -!- TISSUE SPECIFICITY: Widely expressed in various tissues including
CC       heart, lung, kidney, ovary, testis, prostate, placenta, skeletal
CC       Low levels in the liver, thymus and leukocytes. In the adult
CC       brain, broadly expressed in amygdala, caudate nucleus, corpus
CC       callosum, hippocampus, hypothalamus, substantia nigra, subthalamic
CC       nucleus, and thalamus. High levels in fetal tissues, especially
CC       brain.
CC   -!- PTM: Phosphorylated in vitro by MAPK8/JNK1 on Ser-739. Mutant ATN1
CC       sequences with expanded poly-Asn (polyQ) traits are more slowly
CC       phosphorylated.
CC   -!- PTM: Proteolytically cleaved, probably in the nucleus, to produce
CC       two C-terminal fragments of 140 kDa (F1) and 125 kDa (F2) each
CC       containing poly-Asn (polyQ) tracts. F2 is produced by cleavage by
CC       caspases and is exported into the cytoplasm. In vitro, cleavage
CC       increases with an increase in the number of polyQ tracts. C-
CC       terminal proteolytic products appear to be the cause of cell
CC       toxicity. In vitro cleavage at Asp-109.
CC   -!- POLYMORPHISM: The poly-Gln region of ATN1 is highly polymorphic (7
CC       to 23 repeats) in the normal population and is expanded to about
CC       49-75 repeats in DRPLA and HRS patients. Longer expansions result
CC       in earlier onset and more severe clinical manifestations of the
CC       disease.
CC   -!- DISEASE: Defects in ATN1 are the cause of dentatorubral-
CC       pallidoluysian atrophy (DRPLA) [MIM:125370]. DRPLA is an autosomal
CC       dominant neurodegenerative disorder characterized by a loss of
CC       neurons in the dentate nucleus, rubrum, glogus pallidus and
CC       Luys'body. Clinical features are myoclonus epilepsy, dementia, and
CC       cerebellar ataxia. Onset of the disease occurs usually in the
CC       second decade of life and death in the fourth.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA07534.1; Type=Frameshift; Positions=961, 970, 977, 980, 983, 1005;
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/ATN1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D31840; BAA06626.1; -; mRNA.
DR   EMBL; D38529; BAA07534.1; ALT_FRAME; mRNA.
DR   EMBL; U23851; AAB50276.1; -; mRNA.
DR   EMBL; U47924; AAB51321.1; -; Genomic_DNA.
DR   EMBL; D63808; BAA23631.1; -; Genomic_DNA.
DR   IPI; IPI00005502; -.
DR   PIR; G01763; G01763.
DR   PIR; S50832; S50832.
DR   RefSeq; NP_001007027.1; NM_001007026.1.
DR   RefSeq; NP_001931.2; NM_001940.3.
DR   UniGene; Hs.143766; -.
DR   ProteinModelPortal; P54259; -.
DR   IntAct; P54259; 85.
DR   MINT; MINT-92928; -.
DR   STRING; P54259; -.
DR   PhosphoSite; P54259; -.
DR   DMDM; 29429203; -.
DR   PRIDE; P54259; -.
DR   DNASU; 1822; -.
DR   Ensembl; ENST00000356654; ENSP00000349076; ENSG00000111676.
DR   Ensembl; ENST00000396684; ENSP00000379915; ENSG00000111676.
DR   Ensembl; ENST00000544325; ENSP00000441744; ENSG00000111676.
DR   GeneID; 1822; -.
DR   KEGG; hsa:1822; -.
DR   UCSC; uc001qrw.1; human.
DR   CTD; 1822; -.
DR   GeneCards; GC12P007033; -.
DR   H-InvDB; HIX0079489; -.
DR   HGNC; HGNC:3033; ATN1.
DR   HPA; HPA031619; -.
DR   MIM; 125370; phenotype.
DR   MIM; 607462; gene.
DR   neXtProt; NX_P54259; -.
DR   Orphanet; 101; Dentatorubral-pallidoluysian atrophy.
DR   PharmGKB; PA27487; -.
DR   eggNOG; NOG331121; -.
DR   HOVERGEN; HBG075369; -.
DR   InParanoid; P54259; -.
DR   KO; K05626; -.
DR   OMA; PHVTPNL; -.
DR   OrthoDB; EOG4RFKT4; -.
DR   PhylomeDB; P54259; -.
DR   GenomeRNAi; 1822; -.
DR   NextBio; 7425; -.
DR   ArrayExpress; P54259; -.
DR   Bgee; P54259; -.
DR   CleanEx; HS_ATN1; -.
DR   Genevestigator; P54259; -.
DR   GermOnline; ENSG00000111676; Homo sapiens.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0031252; C:cell leading edge; IEA:Compara.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0016363; C:nuclear matrix; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0003714; F:transcription corepressor activity; IDA:UniProtKB.
DR   GO; GO:0016477; P:cell migration; IEA:Compara.
DR   GO; GO:0007417; P:central nervous system development; TAS:ProtInc.
DR   GO; GO:0030011; P:maintenance of cell polarity; IEA:Compara.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0051402; P:neuron apoptotic process; IDA:UniProtKB.
DR   GO; GO:0045664; P:regulation of neuron differentiation; IEA:Compara.
DR   GO; GO:0009404; P:toxin metabolic process; IEA:Compara.
DR   GO; GO:0006351; P:transcription, DNA-dependent; IEA:UniProtKB-KW.
DR   InterPro; IPR017993; Atrophin-1.
DR   InterPro; IPR002951; Atrophin-like.
DR   Pfam; PF03154; Atrophin-1; 2.
DR   PRINTS; PR01222; ATROPHIN.
PE   1: Evidence at protein level;
KW   Acetylation; Cell junction; Complete proteome; Cytoplasm; Epilepsy;
KW   Neurodegeneration; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Triplet repeat expansion.
FT   CHAIN         1   1190       Atrophin-1.
FT                                /FTId=PRO_0000064730.
FT   REGION      517    567       Involved in binding BAIAP2.
FT   REGION      879    894       Required for interaction with FAT1.
FT   MOTIF        16     32       Nuclear localization signal.
FT   MOTIF      1033   1041       Nuclear export signal.
FT   COMPBIAS     73     82       Glu/Ser-rich.
FT   COMPBIAS    302    305       Poly-Pro.
FT   COMPBIAS    376    382       Poly-Ser.
FT   COMPBIAS    386    397       Poly-Ser.
FT   COMPBIAS    442    447       Poly-Pro.
FT   COMPBIAS    479    483       Poly-His.
FT   COMPBIAS    484    502       Poly-Gln.
FT   COMPBIAS    509    512       Poly-Pro.
FT   COMPBIAS    569    579       Poly-Ser.
FT   COMPBIAS    709    712       Poly-Pro.
FT   COMPBIAS    807    820       Ala/Arg-rich.
FT   COMPBIAS    821    832       Arg/Glu-rich (mixed charge).
FT   COMPBIAS    930    939       Arg/Glu-rich (mixed charge).
FT   SITE        109    110       Cleavage.
FT   MOD_RES      34     34       Phosphoserine.
FT   MOD_RES      77     77       Phosphoserine.
FT   MOD_RES      79     79       Phosphoserine.
FT   MOD_RES     101    101       Phosphoserine.
FT   MOD_RES     103    103       Phosphoserine.
FT   MOD_RES     107    107       Phosphoserine.
FT   MOD_RES     112    112       Phosphoserine.
FT   MOD_RES     119    119       Phosphoserine.
FT   MOD_RES     632    632       Phosphoserine.
FT   MOD_RES     641    641       N6-acetyllysine.
FT   MOD_RES     645    645       Phosphoserine.
FT   MOD_RES     651    651       Phosphothreonine.
FT   MOD_RES     653    653       Phosphothreonine.
FT   MOD_RES     661    661       Phosphoserine.
FT   MOD_RES     669    669       Phosphothreonine.
FT   MOD_RES     734    734       Phosphotyrosine.
FT   MOD_RES     739    739       Phosphoserine; by MAPK8.
FT   MOD_RES     746    746       Phosphoserine.
FT   MOD_RES     748    748       Phosphoserine.
FT   VARIANT     339    339       M -> I (in dbSNP:rs1058045).
FT                                /FTId=VAR_030937.
FT   VARIANT     484    488       Missing.
FT                                /FTId=VAR_064038.
FT   MUTAGEN     109    109       D->N: Prevents cleavage and suppresses
FT                                apoptosis.
FT   MUTAGEN     739    739       S->A: Abolishes phosphorylation.
FT   CONFLICT     94     94       Missing (in Ref. 3; AAB50276).
FT   CONFLICT    333    333       H -> Y (in Ref. 1; BAA06626).
FT   CONFLICT   1033   1033       A -> G (in Ref. 1; BAA06626).
SQ   SEQUENCE   1190 AA;  125414 MW;  B47603486C672637 CRC64;
     MKTRQNKDSM SMRSGRKKEA PGPREELRSR GRASPGGVST SSSDGKAEKS RQTAKKARVE
     EASTPKVNKQ GRSEEISESE SEETNAPKKT KTEQELPRPQ SPSDLDSLDG RSLNDDGSSD
     PRDIDQDNRS TSPSIYSPGS VENDSDSSSG LSQGPARPYH PPPLFPPSPQ PPDSTPRQPE
     ASFEPHPSVT PTGYHAPMEP PTSRMFQAPP GAPPPHPQLY PGGTGGVLSG PPMGPKGGGA
     ASSVGGPNGG KQHPPPTTPI SVSSSGASGA PPTKPPTTPV GGGNLPSAPP PANFPHVTPN
     LPPPPALRPL NNASASPPGL GAQPLPGHLP SPHAMGQGMG GLPPGPEKGP TLAPSPHSLP
     PASSSAPAPP MRFPYSSSSS SSAAASSSSS SSSSSASPFP ASQALPSYPH SFPPPTSLSV
     SNQPPKYTQP SLPSQAVWSQ GPPPPPPYGR LLANSNAHPG PFPPSTGAQS TAHPPVSTHH
     HHHQQQQQQQ QQQQQQQQQQ QQHHGNSGPP PPGAFPHPLE GGSSHHAHPY AMSPSLGSLR
     PYPPGPAHLP PPHSQVSYSQ AGPNGPPVSS SSNSSSSTSQ GSYPCSHPSP SQGPQGAPYP
     FPPVPTVTTS SATLSTVIAT VASSPAGYKT ASPPGPPPYG KRAPSPGAYK TATPPGYKPG
     SPPSFRTGTP PGYRGTSPPA GPGTFKPGSP TVGPGPLPPA GPSGLPSLPP PPAAPASGPP
     LSATQIKQEP AEEYETPESP VPPARSPSPP PKVVDVPSHA SQSARFNKHL DRGFNSCARS
     DLYFVPLEGS KLAKKRADLV EKVRREAEQR AREEKERERE REREKERERE KERELERSVK
     LAQEGRAPVE CPSLGPVPHR PPFEPGSAVA TVPPYLGPDT PALRTLSEYA RPHVMSPGNR
     NHPFYVPLGA VDPGLLGYNV PALYSSDPAA REREREARER DLRDRLKPGF EVKPSELEPL
     HGVPGPGLDP FPRHGGLALQ PGPPGLHPFP FHPSLGPLER ERLALAAGPA LRPDMSYAER
     LAAERQHAER VAALGNDPLA RLQMLNVTPH HHQHSHIHSH LHLHQQDAIH AASASVHPLI
     DPLASGSHLT RIPYPAGTLP NPLLPHPLHE NEVLRHQLFA APYRDLPASL SAPMSAAHQL
     QAMHAQSAEL QRLALEQQQW LHAHHPLHSV PLPAQEDYYS HLKKESDKPL
//
ID   HPBP1_HUMAN             Reviewed;         362 AA.
AC   Q9NZL4; B3KQP0; O95351; Q6ZNU5;
DT   25-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   28-NOV-2012, entry version 92.
DE   RecName: Full=Hsp70-binding protein 1;
DE            Short=HspBP1;
DE   AltName: Full=Heat shock protein-binding protein 1;
DE   AltName: Full=Hsp70-binding protein 2;
DE            Short=HspBP2;
DE   AltName: Full=Hsp70-interacting protein 1;
DE   AltName: Full=Hsp70-interacting protein 2;
GN   Name=HSPBP1; Synonyms=HSPBP; ORFNames=PP1845;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT 25-GLY--GLY-27 DEL,
RP   FUNCTION, INTERACTION WITH HSPA1A, AND TISSUE SPECIFICITY.
RC   TISSUE=Heart;
RX   MEDLINE=99047674; PubMed=9830037; DOI=10.1074/jbc.273.49.32883;
RA   Raynes D.A., Guerriero V. Jr.;
RT   "Inhibition of Hsp70 ATPase activity and protein renaturation by a
RT   novel Hsp70-binding protein.";
RL   J. Biol. Chem. 273:32883-32888(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND POLYMORPHISM OF
RP   POLY-GLY REGION.
RC   TISSUE=Heart;
RX   MEDLINE=20246310; PubMed=10786638; DOI=10.1016/S0167-4781(99)00238-9;
RA   Guerriero V. Jr., Raynes D.A.;
RT   "Isolation and characterization of isoforms of HspBP1, inhibitors of
RT   Hsp70.";
RL   Biochim. Biophys. Acta 1490:203-207(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT 25-GLY--GLY-27
RP   DEL.
RA   Tanimura S., Tsujimoto M., Kohno M.;
RL   Submitted (NOV-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H.,
RA   Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y.,
RA   Shu H., Chen X., Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S.,
RA   Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   25-GLY--GLY-27 DEL.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   25-GLY--GLY-27 DEL.
RC   TISSUE=Lung, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH HSPA1A.
RX   PubMed=12651857; DOI=10.1074/jbc.M301109200;
RA   McLellan C.A., Raynes D.A., Guerriero V. Jr.;
RT   "HspBP1, an Hsp70 cochaperone, has two structural domains and is
RT   capable of altering the conformation of the Hsp70 ATPase domain.";
RL   J. Biol. Chem. 278:19017-19022(2003).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH HSPA1A AND STUB1.
RX   PubMed=15215316; DOI=10.1091/mbc.E04-04-0293;
RA   Alberti S., Boehse K., Arndt V., Schmitz A., Hoehfeld J.;
RT   "The cochaperone HspBP1 inhibits the CHIP ubiquitin ligase and
RT   stimulates the maturation of the cystic fibrosis transmembrane
RT   conductance regulator.";
RL   Mol. Biol. Cell 15:4003-4010(2004).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-354 AND SER-359, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 87-362 IN COMPLEX WITH
RP   HSPA1A.
RX   PubMed=15694338; DOI=10.1016/j.molcel.2004.12.023;
RA   Shomura Y., Dragovic Z., Chang H.-C., Tzvetkov N., Young J.C.,
RA   Brodsky J.L., Guerriero V. Jr., Hartl F.U., Bracher A.;
RT   "Regulation of Hsp70 function by HspBP1: structural analysis reveals
RT   an alternate mechanism for Hsp70 nucleotide exchange.";
RL   Mol. Cell 17:367-379(2005).
CC   -!- FUNCTION: Inhibits HSPA1A chaperone activity by changing the
CC       conformation of the ATP-binding domain of HSPA1A and interfering
CC       with ATP binding. Interferes with ubiquitination mediated by STUB1
CC       and inhibits chaperone-assisted degradation of immature CFTR.
CC   -!- SUBUNIT: Interacts with the ATP-binding domain of HSPA1A. Detected
CC       in a ternary complex containing STUB1, HSPA1A and HSPBP1.
CC   -!- INTERACTION:
CC       P54652:HSPA2; NbExp=3; IntAct=EBI-356763, EBI-356991;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NZL4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NZL4-2; Sequence=VSP_015945;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- SIMILARITY: Contains 4 ARM repeats.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF093420; AAC79703.1; -; mRNA.
DR   EMBL; AF187859; AAF35833.1; -; mRNA.
DR   EMBL; AB020592; BAB18742.1; -; mRNA.
DR   EMBL; AF217996; AAG17238.1; -; mRNA.
DR   EMBL; AK130636; BAC85399.1; -; mRNA.
DR   EMBL; CR457118; CAG33399.1; -; mRNA.
DR   EMBL; AK075293; BAG52102.1; -; mRNA.
DR   EMBL; BC001236; AAH01236.1; -; mRNA.
DR   EMBL; BC002373; AAH02373.1; -; mRNA.
DR   IPI; IPI00100748; -.
DR   IPI; IPI00442503; -.
DR   RefSeq; NP_001123578.1; NM_001130106.1.
DR   RefSeq; NP_036399.3; NM_012267.4.
DR   UniGene; Hs.53066; -.
DR   PDB; 1XQR; X-ray; 2.10 A; A/B=87-362.
DR   PDB; 1XQS; X-ray; 2.90 A; A/B=87-362.
DR   PDBsum; 1XQR; -.
DR   PDBsum; 1XQS; -.
DR   ProteinModelPortal; Q9NZL4; -.
DR   SMR; Q9NZL4; 87-353.
DR   IntAct; Q9NZL4; 8.
DR   MINT; MINT-1158196; -.
DR   STRING; Q9NZL4; -.
DR   PhosphoSite; Q9NZL4; -.
DR   DMDM; 74734730; -.
DR   PaxDb; Q9NZL4; -.
DR   PRIDE; Q9NZL4; -.
DR   DNASU; 23640; -.
DR   Ensembl; ENST00000255631; ENSP00000255631; ENSG00000133265.
DR   Ensembl; ENST00000433386; ENSP00000398244; ENSG00000133265.
DR   GeneID; 23640; -.
DR   KEGG; hsa:23640; -.
DR   UCSC; uc002qkc.3; human.
DR   CTD; 23640; -.
DR   GeneCards; GC19M055773; -.
DR   H-InvDB; HIX0015460; -.
DR   HGNC; HGNC:24989; HSPBP1.
DR   HPA; CAB005865; -.
DR   MIM; 612939; gene.
DR   neXtProt; NX_Q9NZL4; -.
DR   PharmGKB; PA164720725; -.
DR   eggNOG; NOG235694; -.
DR   HOVERGEN; HBG053282; -.
DR   InParanoid; Q9NZL4; -.
DR   KO; K09562; -.
DR   OrthoDB; EOG4ZKJN2; -.
DR   EvolutionaryTrace; Q9NZL4; -.
DR   GenomeRNAi; 23640; -.
DR   NextBio; 46437; -.
DR   ArrayExpress; Q9NZL4; -.
DR   Bgee; Q9NZL4; -.
DR   Genevestigator; Q9NZL4; -.
DR   GermOnline; ENSG00000133265; Homo sapiens.
DR   GO; GO:0004857; F:enzyme inhibitor activity; TAS:ProtInc.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:BHF-UCL.
DR   GO; GO:0031398; P:positive regulation of protein ubiquitination; IDA:BHF-UCL.
DR   GO; GO:0006457; P:protein folding; TAS:ProtInc.
DR   Gene3D; 1.25.10.10; ARM-like; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   SUPFAM; SSF48371; ARM-type_fold; 1.
DR   PROSITE; PS50176; ARM_REPEAT; FALSE_NEG.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat.
FT   CHAIN         1    362       Hsp70-binding protein 1.
FT                                /FTId=PRO_0000084035.
FT   REPEAT      135    177       ARM 1.
FT   REPEAT      180    220       ARM 2.
FT   REPEAT      223    262       ARM 3.
FT   REPEAT      265    304       ARM 4.
FT   COMPBIAS     21     40       Gly-rich.
FT   MOD_RES     354    354       Phosphoserine.
FT   MOD_RES     359    359       Phosphoserine.
FT   VAR_SEQ     207    309       Missing (in isoform 2).
FT                                /FTId=VSP_015945.
FT   VARIANT      25     27       Missing.
FT                                /FTId=VAR_023645.
FT   HELIX        90    104
FT   HELIX       113    134
FT   HELIX       137    145
FT   HELIX       148    154
FT   TURN        155    158
FT   HELIX       162    176
FT   HELIX       180    188
FT   HELIX       191    201
FT   HELIX       205    219
FT   HELIX       223    231
FT   HELIX       234    243
FT   HELIX       247    263
FT   HELIX       265    267
FT   HELIX       268    273
FT   HELIX       276    284
FT   HELIX       291    303
FT   HELIX       307    314
FT   HELIX       316    318
FT   HELIX       320    331
FT   HELIX       335    337
FT   HELIX       338    351
SQ   SEQUENCE   362 AA;  39474 MW;  2B6AAB4161D5A326 CRC64;
     MSDEGSRGSR LPLALPPASQ GCSSGGGGGG GGGSSAGGSG NSRPPRNLQG LLQMAITAGS
     EEPDPPPEPM SEERRQWLQE AMSAAFRGQR EEVEQMKSCL RVLSQPMPPT AGEAEQAADQ
     QEREGALELL ADLCENMDNA ADFCQLSGMH LLVGRYLEAG AAGLRWRAAQ LIGTCSQNVA
     AIQEQVLGLG ALRKLLRLLD RDACDTVRVK ALFAISCLVR EQEAGLLQFL RLDGFSVLMR
     AMQQQVQKLK VKSAFLLQNL LVGHPEHKGT LCSMGMVQQL VALVRTEHSP FHEHVLGALC
     SLVTDFPQGV RECREPELGL EELLRHRCQL LQQHEEYQEE LEFCEKLLQT CFSSPADDSM
     DR
//
ID   1433B_MOUSE             Reviewed;         246 AA.
AC   Q9CQV8; O70455; Q3TY33; Q3UAN6;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   09-JAN-2013, entry version 113.
DE   RecName: Full=14-3-3 protein beta/alpha;
DE   AltName: Full=Protein kinase C inhibitor protein 1;
DE            Short=KCIP-1;
DE   Contains:
DE     RecName: Full=14-3-3 protein beta/alpha, N-terminally processed;
GN   Name=Ywhab;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6J;
RA   Karpitskiy V.V., Shaw A.S.;
RL   Submitted (APR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J;
RC   TISSUE=Bone marrow, Embryo, Kidney, Liver, Thymus, and Visual cortex;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   PROTEIN SEQUENCE OF 1-12; 14-57; 61-70; 84-117; 128-169; 196-246 AND
RP   215-224, AND MASS SPECTROMETRY.
RC   STRAIN=C57BL/6, and OF1; TISSUE=Brain, and Hippocampus;
RA   Lubec G., Kang S.U., Sunyer B., Chen W.-Q.;
RL   Submitted (JAN-2009) to UniProtKB.
RN   [4]
RP   NITRATION [LARGE SCALE ANALYSIS] AT TYR-84 AND TYR-106, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain;
RX   PubMed=16800626; DOI=10.1021/bi060474w;
RA   Sacksteder C.A., Qian W.-J., Knyushko T.V., Wang H., Chin M.H.,
RA   Lacan G., Melega W.P., Camp D.G. II, Smith R.D., Smith D.J.,
RA   Squier T.C., Bigelow D.J.;
RT   "Endogenously nitrated proteins in mouse brain: links to
RT   neurodegenerative disease.";
RL   Biochemistry 45:8009-8022(2006).
RN   [5]
RP   INTERACTION WITH PRKCE.
RX   PubMed=18604201; DOI=10.1038/ncb1749;
RA   Saurin A.T., Durgan J., Cameron A.J., Faisal A., Marber M.S.,
RA   Parker P.J.;
RT   "The regulated assembly of a PKCepsilon complex controls the
RT   completion of cytokinesis.";
RL   Nat. Cell Biol. 10:891-901(2008).
RN   [6]
RP   INTERACTION WITH SAMSN1.
RX   PubMed=20478393; DOI=10.1016/j.biocel.2010.05.004;
RA   Brandt S., Ellwanger K., Beuter-Gunia C., Schuster M., Hausser A.,
RA   Schmitz I., Beer-Hammer S.;
RT   "SLy2 targets the nuclear SAP30/HDAC1 complex.";
RL   Int. J. Biochem. Cell Biol. 42:1472-1481(2010).
CC   -!- FUNCTION: Adapter protein implicated in the regulation of a large
CC       spectrum of both general and specialized signaling pathways. Binds
CC       to a large number of partners, usually by recognition of a
CC       phosphoserine or phosphothreonine motif. Binding generally results
CC       in the modulation of the activity of the binding partner. Negative
CC       regulator of osteogenesis. Blocks the nuclear translocation of the
CC       phosphorylated form (by AKT1) of SRPK2 and antagonizes its
CC       stimulatory effect on cyclin D1 expression resulting in blockage
CC       of neuronal apoptosis elicited by SRPK2 (By similarity).
CC   -!- SUBUNIT: Homodimer, and heterodimer with YWHAG, YWHAE and YWHAQ.
CC       Interacts with SSH1 and TORC2/CRTC2. Interacts with GAB2 and YAP1
CC       (phosphorylated form) (By similarity). Interacts with SAMSN1.
CC       Interacts with PKA-phosphorylated AANAT (By similarity). Interacts
CC       with the phosphorylated (by AKT1) form of SRPK2 (By similarity).
CC       Interacts with PRKCE (phosphorylated form).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Melanosome (By
CC       similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=Long;
CC         IsoId=Q9CQV8-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=Q9CQV8-2; Sequence=VSP_018634;
CC         Note=No experimental confirmation available. Contains a
CC         N-acetylmethionine at position 1 (By similarity);
CC   -!- PTM: Isoform alpha differs from isoform beta in being
CC       phosphorylated (By similarity).
CC   -!- PTM: Isoform Short contains a N-acetylmethionine at position 1 (By
CC       similarity).
CC   -!- SIMILARITY: Belongs to the 14-3-3 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF058797; AAC14343.1; -; mRNA.
DR   EMBL; AK002632; BAB22246.1; -; mRNA.
DR   EMBL; AK004872; BAB23631.1; -; mRNA.
DR   EMBL; AK011389; BAB27587.1; -; mRNA.
DR   EMBL; AK083367; BAC38886.1; -; mRNA.
DR   EMBL; AK144061; BAE25678.1; -; mRNA.
DR   EMBL; AK150414; BAE29538.1; -; mRNA.
DR   EMBL; AK151294; BAE30278.1; -; mRNA.
DR   EMBL; AK158932; BAE34730.1; -; mRNA.
DR   IPI; IPI00230682; -.
DR   IPI; IPI00760000; -.
DR   RefSeq; NP_061223.2; NM_018753.6.
DR   UniGene; Mm.34319; -.
DR   PDB; 4GNT; X-ray; 2.41 A; A=1-239.
DR   PDBsum; 4GNT; -.
DR   ProteinModelPortal; Q9CQV8; -.
DR   SMR; Q9CQV8; 1-234.
DR   IntAct; Q9CQV8; 611.
DR   STRING; Q9CQV8; -.
DR   PhosphoSite; Q9CQV8; -.
DR   UCD-2DPAGE; Q9CQV8; -.
DR   PaxDb; Q9CQV8; -.
DR   PRIDE; Q9CQV8; -.
DR   Ensembl; ENSMUST00000018470; ENSMUSP00000018470; ENSMUSG00000018326.
DR   GeneID; 54401; -.
DR   KEGG; mmu:54401; -.
DR   CTD; 7529; -.
DR   MGI; MGI:1891917; Ywhab.
DR   eggNOG; COG5040; -.
DR   GeneTree; ENSGT00690000101832; -.
DR   HOGENOM; HOG000240379; -.
DR   HOVERGEN; HBG050423; -.
DR   InParanoid; Q9CQV8; -.
DR   KO; K16197; -.
DR   OMA; CNDVLXT; -.
DR   OrthoDB; EOG4N30PR; -.
DR   Reactome; REACT_147847; Translocation of Glut4 to the Plasma Membrane.
DR   NextBio; 311260; -.
DR   ArrayExpress; Q9CQV8; -.
DR   Bgee; Q9CQV8; -.
DR   Genevestigator; Q9CQV8; -.
DR   GermOnline; ENSMUSG00000018326; Mus musculus.
DR   GO; GO:0005813; C:centrosome; IEA:Compara.
DR   GO; GO:0005829; C:cytosol; IEA:Compara.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Compara.
DR   GO; GO:0017053; C:transcriptional repressor complex; IEA:Compara.
DR   GO; GO:0019904; F:protein domain specific binding; IDA:MGI.
DR   GO; GO:0003714; F:transcription corepressor activity; IEA:Compara.
DR   GO; GO:0051220; P:cytoplasmic sequestering of protein; IEA:Compara.
DR   GO; GO:0035308; P:negative regulation of protein dephosphorylation; IEA:Compara.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-dependent; IEA:Compara.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; IEA:Compara.
DR   GO; GO:0006605; P:protein targeting; IDA:MGI.
DR   Gene3D; 1.20.190.20; 14-3-3; 1.
DR   InterPro; IPR000308; 14-3-3.
DR   InterPro; IPR023409; 14-3-3_CS.
DR   InterPro; IPR023410; 14-3-3_domain.
DR   PANTHER; PTHR18860; PTHR18860; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   SMART; SM00101; 14_3_3; 1.
DR   SUPFAM; SSF48445; 14-3-3; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Nitration; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN         1    246       14-3-3 protein beta/alpha.
FT                                /FTId=PRO_0000367902.
FT   INIT_MET      1      1       Removed; alternate (By similarity).
FT   CHAIN         2    246       14-3-3 protein beta/alpha, N-terminally
FT                                processed.
FT                                /FTId=PRO_0000000005.
FT   SITE         58     58       Interaction with phosphoserine on
FT                                interacting protein (By similarity).
FT   SITE        129    129       Interaction with phosphoserine on
FT                                interacting protein (By similarity).
FT   MOD_RES       1      1       N-acetylmethionine; in 14-3-3 protein
FT                                beta/alpha; alternate (By similarity).
FT   MOD_RES       2      2       N-acetylthreonine; in 14-3-3 protein
FT                                beta/alpha, N-terminally processed (By
FT                                similarity).
FT   MOD_RES       6      6       Phosphoserine (By similarity).
FT   MOD_RES      70     70       N6-acetyllysine (By similarity).
FT   MOD_RES      84     84       Nitrated tyrosine.
FT   MOD_RES     106    106       Nitrated tyrosine.
FT   MOD_RES     117    117       N6-acetyllysine (By similarity).
FT   MOD_RES     186    186       Phosphoserine (By similarity).
FT   VAR_SEQ       1      2       Missing (in isoform Short).
FT                                /FTId=VSP_018634.
FT   CONFLICT     10     10       Q -> H (in Ref. 1; AAC14343).
FT   CONFLICT     74     74       N -> D (in Ref. 1; AAC14343).
FT   CONFLICT    126    126       D -> Y (in Ref. 2; BAE29538/BAE30278).
SQ   SEQUENCE   246 AA;  28086 MW;  51C366ED85B38EED CRC64;
     MTMDKSELVQ KAKLAEQAER YDDMAAAMKA VTEQGHELSN EERNLLSVAY KNVVGARRSS
     WRVISSIEQK TERNEKKQQM GKEYREKIEA ELQDICNDVL ELLDKYLILN ATQAESKVFY
     LKMKGDYFRY LSEVASGENK QTTVSNSQQA YQEAFEISKK EMQPTHPIRL GLALNFSVFY
     YEILNSPEKA CSLAKTAFDE AIAELDTLNE ESYKDSTLIM QLLRDNLTLW TSENQGDEGD
     AGEGEN
//
ID   1433B_RAT               Reviewed;         246 AA.
AC   P35213;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   09-JAN-2013, entry version 119.
DE   RecName: Full=14-3-3 protein beta/alpha;
DE   AltName: Full=Prepronerve growth factor RNH-1;
DE   AltName: Full=Protein kinase C inhibitor protein 1;
DE            Short=KCIP-1;
DE   Contains:
DE     RecName: Full=14-3-3 protein beta/alpha, N-terminally processed;
GN   Name=Ywhab;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Brain;
RX   MEDLINE=93164855; PubMed=8381897; DOI=10.1016/0169-328X(93)90082-Z;
RA   Watanabe M., Isobe T., Ichimura T., Kuwano R., Takahashi Y., Kondo H.;
RT   "Molecular cloning of rat cDNAs for beta and gamma subtypes of 14-3-3
RT   protein and developmental changes in expression of their mRNAs in the
RT   nervous system.";
RL   Brain Res. Mol. Brain Res. 17:135-146(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   MEDLINE=96318520; PubMed=8749325;
RA   Takai R., Tanaka E., Miyazaki T., Suda M., Tashiro F.;
RT   "Function of RNH-1/14-3-3 beta gene in cellular differentiation and
RT   proliferation.";
RL   J. Biochem. 118:1045-1053(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 14-57; 63-70; 86-117; 130-159; 161-189 AND
RP   196-224, AND MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain, and Hippocampus;
RA   Lubec G., Kang S.U., Chen W.-Q.;
RL   Submitted (JAN-2009) to UniProtKB.
RN   [5]
RP   PROTEIN SEQUENCE OF 30-43, INTERACTION WITH AANAT, AND MASS
RP   SPECTROMETRY.
RX   PubMed=11427721; DOI=10.1073/pnas.141118798;
RA   Ganguly S., Gastel J.A., Weller J.L., Schwartz C., Jaffe H.,
RA   Namboodiri M.A., Coon S.L., Hickman A.B., Rollag M., Obsil T.,
RA   Beauverger P., Ferry G., Boutin J.A., Klein D.C.;
RT   "Role of a pineal cAMP-operated arylalkylamine N-acetyltransferase/14-
RT   3-3-binding switch in melatonin synthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:8083-8088(2001).
CC   -!- FUNCTION: Adapter protein implicated in the regulation of a large
CC       spectrum of both general and specialized signaling pathways. Binds
CC       to a large number of partners, usually by recognition of a
CC       phosphoserine or phosphothreonine motif. Binding generally results
CC       in the modulation of the activity of the binding partner. Negative
CC       regulator of osteogenesis. Blocks the nuclear translocation of the
CC       phosphorylated form (by AKT1) of SRPK2 and antagonizes its
CC       stimulatory effect on cyclin D1 expression resulting in blockage
CC       of neuronal apoptosis elicited by SRPK2 (By similarity).
CC   -!- SUBUNIT: Homodimer. Interacts with SSH1 and TORC2/CRTC2. Interacts
CC       with ABL1 (phosphorylated form); the interaction results in
CC       cytoplasmic location of ABL1 and inhibition of cABL-mediated
CC       apoptosis. Interacts with ROR2 (dimer); the interaction results in
CC       phosphorylation of YWHAB on tyrosine residues. Interacts with
CC       GAB2, YAP1 and PRKCE (phosphorylated form). Interacts with SAMSN1
CC       (By similarity). Interacts with PKA-phosphorylated AANAT.
CC       Interacts with the phosphorylated (by AKT1) form of SRPK2 (By
CC       similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Melanosome (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=Long;
CC         IsoId=P35213-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=P35213-2; Sequence=VSP_018635;
CC         Note=No experimental confirmation available. Contains a
CC         N-acetylmethionine at position 1 (By similarity);
CC   -!- PTM: The alpha, brain-specific form differs from the beta form in
CC       being phosphorylated (By similarity).
CC   -!- PTM: Isoform Short contains a N-acetylmethionine at position 1 (By
CC       similarity).
CC   -!- SIMILARITY: Belongs to the 14-3-3 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D17446; BAA04260.1; -; mRNA.
DR   EMBL; S55223; AAA13843.1; -; mRNA.
DR   EMBL; S83440; AAB50874.1; -; mRNA.
DR   EMBL; BC076502; AAH76502.1; -; mRNA.
DR   IPI; IPI00230837; -.
DR   IPI; IPI00760126; -.
DR   PIR; A49023; A49023.
DR   RefSeq; NP_062250.1; NM_019377.1.
DR   UniGene; Rn.8653; -.
DR   ProteinModelPortal; P35213; -.
DR   SMR; P35213; 3-233.
DR   IntAct; P35213; 1.
DR   MINT; MINT-270245; -.
DR   STRING; P35213; -.
DR   PhosphoSite; P35213; -.
DR   PRIDE; P35213; -.
DR   Ensembl; ENSRNOT00000016981; ENSRNOP00000016981; ENSRNOG00000010945.
DR   GeneID; 56011; -.
DR   KEGG; rno:56011; -.
DR   UCSC; RGD:61998; rat.
DR   CTD; 7529; -.
DR   RGD; 61998; Ywhab.
DR   eggNOG; COG5040; -.
DR   GeneTree; ENSGT00690000101832; -.
DR   HOGENOM; HOG000240379; -.
DR   HOVERGEN; HBG050423; -.
DR   InParanoid; P35213; -.
DR   KO; K16197; -.
DR   OMA; CNDVLXT; -.
DR   OrthoDB; EOG4N30PR; -.
DR   Reactome; REACT_111984; Signal Transduction.
DR   NextBio; 611079; -.
DR   ArrayExpress; P35213; -.
DR   Genevestigator; P35213; -.
DR   GermOnline; ENSRNOG00000010945; Rattus norvegicus.
DR   GO; GO:0005813; C:centrosome; IEA:Compara.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Compara.
DR   GO; GO:0017053; C:transcriptional repressor complex; IDA:RGD.
DR   GO; GO:0003714; F:transcription corepressor activity; IMP:RGD.
DR   GO; GO:0051220; P:cytoplasmic sequestering of protein; IEA:Compara.
DR   GO; GO:0035308; P:negative regulation of protein dephosphorylation; IEA:Compara.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-dependent; IMP:RGD.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; IEA:Compara.
DR   GO; GO:0051291; P:protein heterooligomerization; IPI:RGD.
DR   GO; GO:0006605; P:protein targeting; IEA:Compara.
DR   Gene3D; 1.20.190.20; 14-3-3; 1.
DR   InterPro; IPR000308; 14-3-3.
DR   InterPro; IPR023409; 14-3-3_CS.
DR   InterPro; IPR023410; 14-3-3_domain.
DR   PANTHER; PTHR18860; PTHR18860; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   SMART; SM00101; 14_3_3; 1.
DR   SUPFAM; SSF48445; 14-3-3; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative initiation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Phosphoprotein; Reference proteome.
FT   CHAIN         1    246       14-3-3 protein beta/alpha.
FT                                /FTId=PRO_0000367904.
FT   INIT_MET      1      1       Removed; alternate (By similarity).
FT   CHAIN         2    246       14-3-3 protein beta/alpha, N-terminally
FT                                processed.
FT                                /FTId=PRO_0000000007.
FT   SITE         58     58       Interaction with phosphoserine on
FT                                interacting protein (By similarity).
FT   SITE        129    129       Interaction with phosphoserine on
FT                                interacting protein (By similarity).
FT   MOD_RES       1      1       N-acetylmethionine; in 14-3-3 protein
FT                                beta/alpha; alternate (By similarity).
FT   MOD_RES       2      2       N-acetylthreonine; in 14-3-3 protein
FT                                beta/alpha, N-terminally processed (By
FT                                similarity).
FT   MOD_RES       6      6       Phosphoserine (By similarity).
FT   MOD_RES      70     70       N6-acetyllysine (By similarity).
FT   MOD_RES     117    117       N6-acetyllysine (By similarity).
FT   MOD_RES     186    186       Phosphoserine (By similarity).
FT   VAR_SEQ       1      2       Missing (in isoform Short).
FT                                /FTId=VSP_018635.
SQ   SEQUENCE   246 AA;  28054 MW;  B663D1F2182F9C43 CRC64;
     MTMDKSELVQ KAKLAEQAER YDDMAAAMKA VTEQGHELSN EERNLLSVAY KNVVGARRSS
     WRVISSIEQK TERNEKKQQM GKEYREKIEA ELQDICSDVL ELLDKYLILN ATHAESKVFY
     LKMKGDYFRY LSEVASGDNK QTTVSNSQQA YQEAFEISKK EMQPTHPIRL GLALNFSVFY
     YEILNSPEKA CSLAKTAFDE AIAELDTLNE ESYKDSTLIM QLLRDNLTLW TSENQGDEGD
     AGEGEN
//
ID   1433E_MOUSE             Reviewed;         255 AA.
AC   P62259; P29360; P42655; Q63631;
DT   05-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   09-JAN-2013, entry version 89.
DE   RecName: Full=14-3-3 protein epsilon;
DE            Short=14-3-3E;
GN   Name=Ywhae;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND DEVELOPMENTAL STAGE.
RC   STRAIN=Swiss; TISSUE=Kidney;
RX   MEDLINE=95269876; PubMed=7750640; DOI=10.1006/dbio.1995.1139;
RA   McConnell J.E., Armstrong J.F., Bard J.B.;
RT   "The mouse 14-3-3 epsilon isoform, a kinase regulator whose expression
RT   pattern is modulated in mesenchyme and neuronal differentiation.";
RL   Dev. Biol. 169:218-228(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=129/Sv;
RA   Takihara Y., Irie K., Nomura M., Motaleb M., Matsumoto K., Shimada K.;
RL   Submitted (SEP-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=ILS, and ISS;
RX   MEDLINE=21363810; PubMed=11471062; DOI=10.1007/s00335-001-1001-x;
RA   Ehringer M.A., Thompson J., Conroy O., Xu Y., Yang F., Canniff J.,
RA   Beeson M., Gordon L., Bennett B., Johnson T.E., Sikela J.M.;
RT   "High-throughput sequence identification of gene coding variants
RT   within alcohol-related QTLs.";
RL   Mamm. Genome 12:657-663(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6; TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 131-141; 154-170 AND 197-215, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, and Hippocampus;
RA   Lubec G., Klug S., Friebe K., Yang J.W., Zigmond M.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [6]
RP   INTERACTION WITH ARHGEF28.
RX   PubMed=11533041; DOI=10.1074/jbc.M107709200;
RA   Zhai J., Lin H., Shamim M., Schlaepfer W.W., Canete-Soler R.;
RT   "Identification of a novel interaction of 14-3-3 with p190RhoGEF.";
RL   J. Biol. Chem. 276:41318-41324(2001).
RN   [7]
RP   INTERACTION WITH NDEL1.
RX   PubMed=12796778; DOI=10.1038/ng1169;
RA   Toyo-oka K., Shionoya A., Gambello M.J., Cardoso C., Leventer R.,
RA   Ward H.L., Ayala R., Tsai L.-H., Dobyns W., Ledbetter D.,
RA   Hirotsune S., Wynshaw-Boris A.;
RT   "14-3-3epsilon is important for neuronal migration by binding to
RT   NUDEL: a molecular explanation for Miller-Dieker syndrome.";
RL   Nat. Genet. 34:274-285(2003).
RN   [8]
RP   INTERACTION WITH GRB10.
RX   PubMed=15722337; DOI=10.1074/jbc.M501477200;
RA   Urschel S., Bassermann F., Bai R.Y., Munch S., Peschel C., Duyster J.;
RT   "Phosphorylation of grb10 regulates its interaction with 14-3-3.";
RL   J. Biol. Chem. 280:16987-16993(2005).
RN   [9]
RP   INTERACTION WITH TIAM2.
RX   PubMed=17320046; DOI=10.1016/j.bbrc.2007.02.028;
RA   Takefuji M., Mori K., Morita Y., Arimura N., Nishimura T.,
RA   Nakayama M., Hoshino M., Iwamatsu A., Murohara T., Kaibuchi K.,
RA   Amano M.;
RT   "Rho-kinase modulates the function of STEF, a Rac GEF, through its
RT   phosphorylation.";
RL   Biochem. Biophys. Res. Commun. 355:788-794(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-210, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=17203969; DOI=10.1021/pr0604155;
RA   Dai J., Jin W.-H., Sheng Q.-H., Shieh C.-H., Wu J.-R., Zeng R.;
RT   "Protein phosphorylation and expression profiling by Yin-yang
RT   multidimensional liquid chromatography (Yin-yang MDLC) mass
RT   spectrometry.";
RL   J. Proteome Res. 6:250-262(2007).
CC   -!- FUNCTION: Adapter protein implicated in the regulation of a large
CC       spectrum of both general and specialized signaling pathways. Binds
CC       to a large number of partners, usually by recognition of a
CC       phosphoserine or phosphothreonine motif. Binding generally results
CC       in the modulation of the activity of the binding partner.
CC   -!- SUBUNIT: Homodimer. Heterodimerizes with YWHAZ (By similarity).
CC       Interacts with NDEL1, ARHGEF28 and TIAM2. Interacts with ABL1
CC       (phosphorylated form); the interaction retains it in the
CC       cytoplasm. Weakly interacts with CDKN1B. Interacts with GAB2 (By
CC       similarity). Interacts with PKA-phosphorylated AANAT (By
CC       similarity). Interacts with phosphorylated GRB10. Interacts with
CC       the phosphorylated (by AKT1) form of SRPK2 (By similarity).
CC   -!- INTERACTION:
CC       Q8CHQ0:Fbxo4; NbExp=2; IntAct=EBI-356480, EBI-3895153;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Melanosome (By
CC       similarity).
CC   -!- DEVELOPMENTAL STAGE: In the E8.5 embryo, expressed throughout the
CC       embryo. Within a day, expression was more marked in mesenchyme
CC       than elsewhere (e.g. epithelial tissue, where it was generally
CC       low), although levels in neural tissue rose again by about E12.5.
CC       This difference was maintained until E15.5 when expression levels
CC       started to drop in most tissues, with those of the nervous system,
CC       tooth, and kidney being exceptions. Strongly expressed in early
CC       mesenchyme. The expression decreased as the mesenchyme
CC       differentiated.
CC   -!- SIMILARITY: Belongs to the 14-3-3 family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z19599; CAA79659.1; -; mRNA.
DR   EMBL; D87663; BAA13424.1; -; mRNA.
DR   EMBL; AF483478; AAL90752.1; -; mRNA.
DR   EMBL; AF483479; AAL90753.1; -; mRNA.
DR   EMBL; BC058686; AAH58686.1; -; mRNA.
DR   IPI; IPI00118384; -.
DR   PIR; I48337; S31975.
DR   RefSeq; NP_033562.3; NM_009536.4.
DR   UniGene; Mm.234700; -.
DR   ProteinModelPortal; P62259; -.
DR   SMR; P62259; 3-232.
DR   IntAct; P62259; 13.
DR   MINT; MINT-209058; -.
DR   STRING; P62259; -.
DR   PhosphoSite; P62259; -.
DR   REPRODUCTION-2DPAGE; P62259; -.
DR   PaxDb; P62259; -.
DR   PRIDE; P62259; -.
DR   Ensembl; ENSMUST00000067664; ENSMUSP00000070993; ENSMUSG00000020849.
DR   GeneID; 22627; -.
DR   KEGG; mmu:22627; -.
DR   CTD; 7531; -.
DR   MGI; MGI:894689; Ywhae.
DR   eggNOG; COG5040; -.
DR   HOGENOM; HOG000240379; -.
DR   HOVERGEN; HBG050423; -.
DR   InParanoid; P62259; -.
DR   KO; K06630; -.
DR   OMA; KESALIM; -.
DR   OrthoDB; EOG4HHP34; -.
DR   Reactome; REACT_147847; Translocation of Glut4 to the Plasma Membrane.
DR   NextBio; 302987; -.
DR   ArrayExpress; P62259; -.
DR   Bgee; P62259; -.
DR   Genevestigator; P62259; -.
DR   GermOnline; ENSMUSG00000020849; Mus musculus.
DR   GO; GO:0033267; C:axon part; IEA:Compara.
DR   GO; GO:0005871; C:kinesin complex; IEA:Compara.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IDA:MGI.
DR   GO; GO:0019904; F:protein domain specific binding; IDA:MGI.
DR   GO; GO:0021987; P:cerebral cortex development; IMP:MGI.
DR   GO; GO:0021766; P:hippocampus development; IMP:MGI.
DR   GO; GO:0035308; P:negative regulation of protein dephosphorylation; IDA:MGI.
DR   GO; GO:0001764; P:neuron migration; IMP:MGI.
DR   GO; GO:0006605; P:protein targeting; IDA:MGI.
DR   Gene3D; 1.20.190.20; 14-3-3; 1.
DR   InterPro; IPR000308; 14-3-3.
DR   InterPro; IPR023409; 14-3-3_CS.
DR   InterPro; IPR023410; 14-3-3_domain.
DR   PANTHER; PTHR18860; PTHR18860; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   SMART; SM00101; 14_3_3; 1.
DR   SUPFAM; SSF48445; 14-3-3; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Phosphoprotein; Reference proteome.
FT   CHAIN         1    255       14-3-3 protein epsilon.
FT                                /FTId=PRO_0000058619.
FT   SITE         57     57       Interaction with phosphoserine on
FT                                interacting protein (By similarity).
FT   SITE        130    130       Interaction with phosphoserine on
FT                                interacting protein (By similarity).
FT   MOD_RES       1      1       N-acetylmethionine (By similarity).
FT   MOD_RES      38     38       Phosphothreonine (By similarity).
FT   MOD_RES      50     50       N6-acetyllysine (By similarity).
FT   MOD_RES      69     69       N6-acetyllysine (By similarity).
FT   MOD_RES     118    118       N6-acetyllysine (By similarity).
FT   MOD_RES     123    123       N6-acetyllysine (By similarity).
FT   MOD_RES     210    210       Phosphoserine.
SQ   SEQUENCE   255 AA;  29174 MW;  07817CCBD1F75B26 CRC64;
     MDDREDLVYQ AKLAEQAERY DEMVESMKKV AGMDVELTVE ERNLLSVAYK NVIGARRASW
     RIISSIEQKE ENKGGEDKLK MIREYRQMVE TELKLICCDI LDVLDKHLIP AANTGESKVF
     YYKMKGDYHR YLAEFATGND RKEAAENSLV AYKAASDIAM TELPPTHPIR LGLALNFSVF
     YYEILNSPDR ACRLAKAAFD DAIAELDTLS EESYKDSTLI MQLLRDNLTL WTSDMQGDGE
     EQNKEALQDV EDENQ
//
